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Abstract
LIQIONG FAN. Covariate Misclassification under Covariate-Adaptive Randomization: Under-
standing the Impact and Method for Bias Correction (Under the direction of SHAROND. YEATTS).
Covariate-adaptive randomization has been frequently used in randomized controlled trials (RCTs)
because it can well balance prognostic factors between treatment groups. However when a subject
is assigned a wrong covariate value or misplaced in a wrong cohort during the randomization
procedure, it may not only impact the balancing of the covariate, but also influence the treatment
assignment based on the assigned cohort. Furthermore, it is preferred that covariates that are
adjusted during the randomization procedure should also be adjusted for in the primary analysis. It
is not clear whether a corrected covariate value, if it could be ascertained, or a misclassified covariate
value should be used for the analysis, since the covariate value is tied both to the randomization
procedure and analytic model. In this research, the impact of such misclassification on the type I
error rate, power for hypothesis testing for the treatment effect and estimation bias of the treatment
effect is explored under covariate-adaptive randomization in Aim 1. In Aim 2, a latent class model,
the Continuous-time Hidden Markov Model (CTHMM) is used to estimate the misclassification
issue with respect to both the estimation of misclassification probabilities and model diagnosis.
An AIC based approach, which is calculated from a modified full data likelihood, is developed to
test the assumption of misclassification. In Aim 3, a two-stage analysis strategy is proposed, which
combines the CTHMM and the Misclassification Simulation-Extrapolation method (MCSIMEX), to
correct the estimation bias of the perfectly measured variable caused by covariate misclassification.
We apply the proposed analysis strategy to data from the Interventional Management of Stroke III
trial to demonstrate the two-stage model.
Keywords: RCT, covariate misclassification, covariate-adaptive randomization, latent class model,
CTHMM, MCSIMEX
vi
1 Introduction & Background
1.1 Introduction
Randomized controlled trials (RCTs) have been widely used to test the treatment effect within
a specific patient population and are considered the gold standard for claiming the efficacy of an
intervention in practice (Chalmers et al., 1981; Moher et al., 2010). One of the key elements of
the RCTs is the randomization procedure, which protects the validity and generalizability of the
result of a trial. Simple randomization is easy to conduct, but balancing of baseline characteristics
among groups is not guaranteed, especially when the sample size is small. Covariate-adaptive
randomization has been frequently used (Thall and Wathen, 2005; Krag et al., 2010; Atagi et al.,
2012; Sherrington et al., 2014; Ellis et al., 2014; Ybarra et al., 2013; Ersek et al., 2012; Weir and Lees,
2003) in RCTs because it can produce well-balanced groups and therefore, presents a more powerful
and generalizable result. However, the operating characteristics of the test of the treatment effect
are different under simple randomization and covariate-adaptive randomization (Hu and Hu, 2012;
Shao and Yu, 2013). In order to obtain a valid test result under covariate-adaptive randomization,
a correctly specified analytic model, which includes adjustments for all covariates used during the
randomization procedure, is required.
On the other hand, the impact of covariate adjustment in the logistic regression model differs from
that in the classic linear regression (Robinson and Jewell, 1991). With classic linear regression, an
unbiased estimate for treatment effect can always be obtained, whether or not the model includes
adjustment for covariates associated with the outcome, as long as there is no correlation between the
treatment and the covariates (Robinson and Jewell, 1991). However, the treatment effect estimate
is less precise, and the corresponding test is less powerful, when the model does not adjust for
prognostic covariates. Under logistic regression, failure to adjust for a prognostic covariate (i.e., a
covariate which is associated with the outcome) will always lead to biased estimate of the treatment
effect, although adjusting for the covariate will increase the variance of the treatment effect estimate.
That is, covariate adjustment will reduce the precision of the estimate but still result in a power gain
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in terms of the asymptotic relative efficiency (Robinson and Jewell, 1991). Since RCTs often employ
a primary analysis based on the logistic regression model in order to analyze binary outcomes, it is
important to understand the implications of the selected randomization procedure on the analysis
plan.
Because of the requirement of adjusting for the covariates included in the randomization algorithm,
the incorrect measurement of those covariates could potentially cause problems for the pursuit of
both appropriately balanced treatment arms and effective prognostic adjustments under covariate-
adaptive randomization. Measurement error has been a long-standing topic in statistical literature.
Misclassification is a special case of measurement error when the mis-measured variable is categori-
cal. When a subject is assigned to a wrong covariate value or mis-placed into a wrong cohort during
randomization procedure, it is equivalent to misclassification of the covariate. In an observational
study, ignoring measurement error via näıve analysis using mis-measured data will cause biased
estimation and power loss with respect to the misclassified variable itself (Buzas, 2006; Carroll
et al., 2006). Methods have been developed to correct such bias (Begg and Lagakos, 1993). How-
ever, in a RCT setting, the emphasis is much more likely to be the treatment variable, which is
considered perfectly recorded, after adjusting for the covariates rather than on the mis-measured
covariates themselves. While the impact of covariate misclassification on the estimation of the per-
fectly measured variable during analysis has been demonstrated in previous observational studies
(Buonaccorsi et al., 2005), few researchers have been actually focused on the perfectly measured
variable in experimental studies especially that under covariate-adaptive randomization. When
a trial employs covariate-adaptive randomization, the misclassified covariate is tied both to the
treatment assignment and the analysis. Therefore, it is important to understand the impact of
covariate misclassification on the treatment effect estimate, as well as the power and type I error
of the corresponding hypothesis test under covariate-adaptive randomization. Whether and how to
adjust for error-prone (misclassified) covariates in the analysis needs to be established and ratio-
nalized. Furthermore, presumably the bias will apply to the treatment effect estimation, indicating
that methods that are specifically designed for bias correction for the treatment effect estimation
need to be taken into consideration.
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Misclassification error can be well-characterized by a misclassification matrix, if both the truth and
the misclassified version of the covariate are known. In many real world applications, however,
the truth is unobservable; in order to correct the bias in this case, additional information such
as internal/external validation data sets or repeated measurements/replicas are necessary so that
misclassification probabilities can be estimated.
In this thesis, the focus will be on effect estimation of the perfectly measured variable, i.e. the
treatment effect, when categorical covariates are subject to misclassification. First, the impact of
varying rates of covariate misclassification on the type I error rate and power associated with the
hypothesis testing for the treatment effect, as well as bias of its estimation, under covariate-adaptive
randomization is explored, where the misclassified covariate is adjusted during the randomization
procedure. Because binary outcomes and/or event frequency are commonly encountered types of
outcomes in medical research, the focus is on the generalized linear regression model. Secondly,
given the impact of covariate misclassification on the treatment effect estimation, a method that
can account for the uncertainty of the covariate measurement will be developed, thus providing a
more accurate estimate of the treatment effect and potentially improving the power to detect it.
Finally, the method will be applied to the data from a real trial example, and the results using the
developed method compared to those of the näıve analysis, adjusting for the misclassified covariate,
and the corrected model, adjusting for the corrected covariate.
1.1.1 Specific Aims
(1) Specific Aim 1
Explore the operating characteristics (type I error, power, and bias of treatment effect estima-
tion) of different analysis strategies for dealing with covariate misclassification under covariate-
adaptive randomization.
(2) Specific Aim 2
Assess the ability of the Continuous-Time Hidden Markov Model (CTHMM) to estimate the
misclassification probabilities based on a repeatedly measured error-prone variable including
3
parameter identifiability and accuracy of the estimates.
(3) Specific Aim 3
Combine the CTHMM and MisClassification Simulation-Extrapolation method (MCSIMEX)
in order to correct the bias of the treatment effect estimation and assess its robustness. Ana-
lyze real trial data (IMS III) using the joint modeling strategy in order to both estimate the
misclassification probabilities and appropriately correct the estimation of the treatment effect,
comparing with naive analysis.
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1.2 Background
1.2.1 Motivation & Clinical Relevance
The motivation of this study came from two multicenter RCTs, both of which employed covariate-
adaptive randomization. For the Interventional Management of Stroke (IMS) III Trial (Broderick,
2013), the primary objective was to determine the treatment effect of endovascular therapy following
intravenous (IV) rt-PA, initiated within 3 hours of symptom onset of ischemic stroke, compared
to the standard intravenous rt-PA approach alone. One of the covariates adjusted for during the
randomization procedure was stroke severity defined based on the National Institute of Health
Stroke Scale (NIHSS) score, ranging from 0-42. For the severity designation, the baseline NIHSS
was dichotomized as ≤ 19 VS. ≥ 20, representing mild to moderate stroke and severe stroke,
respectively. The NIHSS was also evaluated repeatedly at 40 minutes post IV tPA initiation, 24
hours and 5 days or discharge. The primary outcome of the IMS III trial was functional recovery
based on the modified Rankin Scale (mRS) evaluated at 3 month after stroke onset, which was
also dichotomized as good outcome (mRS 0-2) VS. poor (mRS > 2). The NIHSS is an important
prognostic covariate in that it has been shown to predict outcome well after stroke (Muir et al.,
1996; Adams et al., 1999; Frankel et al., 2000; De Haan et al., 1993; Harrison et al., 2013; Glymour
et al., 2007). However, the NIHSS was categorized for both randomization and analysis, rather than
used in its original ordinal scale, due to ease of interpretation and flexibility of model assumptions.
During the trial, data were reviewed by independent clinical monitors. About 2% of the subjects
with severe stroke (NIHSS ≥ 20) were identified as having been misclassified as moderate stroke
(NIHSS ≤ 19) during randomization, and a similar error rate was found among subjects with
moderate stroke for their baseline severity evaluation.
The Progesterone for Traumatic Brain Injury: Experimental Clinical Treatment (ProTECTTM)
III Trial (Wright, 2014) was designed to determine the efficacy of intravenous progesterone admin-
istration, started within 4 hours of traumatic brain injury (TBI), compared to placebo. In the
ProTECT Trial, one of the covariates adjusted for during the randomization procedure was the
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severity of TBI based on the Glasgow Coma Scale (GCS) or its subdomain of motor score (Motor)
if the subject was intubated. The original scale for GCS ranges from 3 to 15, with 3 representing
a deep coma and 15 fully awake. The scale was trichotomized into moderate TBI (GCS 9-12),
moderate-to-severe TBI (GCS 6-8 or Motor 4-5) and most severe TBI (GCS 4-5 or Motor 2-3).
The GCS was evaluated repeatedly while subjects were hospitalized. The primary outcome was
functional recovery defined by the Glasgow Outcome Scale-Extended (GOS-E) score at 6 months
after the injury. A favorable outcome was defined as GOS-E 5-8. However, after data were reviewed
by the trial monitors, the severity stratum were identified being recorded incorrectly among some
subjects. In this trial, 8% of the subjects with most severe traumatic brain injury (TBI) were
misclassified as moderate-to-severe TBI at baseline; 7% and 3% of moderate-to-severe TBI were
misclassified as most severe and moderate TBI respectively; 1% and 14% of moderate TBI were
misclassified as most severe and moderate-to-severe TBI. (Supplement Table 1) However, the use of
GCS for evaluation is somewhat controversial due to its poor inter-rater reliability (Green, 2011).
Therefore, the possibility of being misclassified based on GCS may be even higher in the ProTECT
trial.
It is common in practice to use some scores to quantify disease severity, like the NIHSS for stroke and
the GCS for TBI. Usually such scores have a relatively wide range so that different manifestations
of the disease can be evaluated and incorporated to better describe the disease severity. However,
the original scale may not be very helpful, from a clinical or a statistical perspective. Clinically, and
most importantly, the association between disease severity and the outcome may not necessarily
change in a linear fashion; for example subjects who scored 10 or 12 on the NIHSS may have the same
probability of achieving a favorable outcome defined as mRS 0-2 at 90 days after stroke. Thus, there
may be biological rationale for categorizing scores to better reflect the ordinal association between
disease severity and the outcome. Statistically, while information may be lost when a continuous
or ordinal measure (with wide range) is categorized, such categorization is sometimes necessary for
model validity. First of all, the normality assumption is often violated when treating the original
score as a continuous predictive variable in the model. Secondly, if the generalized linear regression
model is used for analysis, the linearity in the logit assumption may also be questionable, which
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may result in unreliable estimates. Therefore, a categorized or ordinal version with fewer levels of
the covariate scores may be preferred instead.
However, although generic cutoff points that are commonly used in practice may exist for some
scores, the choice of cutoff points is often data driven. For example, Schlegel et al. (2003) use 5 and
13 as cutoff points for the NIHSS to predict care level after acute hospitalization of stroke patients.
In another study, the same authors use 5, 10 and 15 as cutoff points for the NIHSS (Schlegel et al.,
2004) to predict care level among stroke patients treated with rt-PA. Briggs et al. (2001) define
mild stroke as an NIHSS < 8 in order to determine the necessity of intensive care for the study
with respect to favorable outcome rate, compared to admission to ward unit. Fischer et al. (2005)
also use cutoff points of 10 or 12 to associate NIHSS to arteriographic findings in acute ischemic
stroke. Given the uncertainty of these cutoff points, together with the potential evaluation error,
categorizing such covariates may introduce more or less misclassification of the data, resulting in
a biased estimate for the treatment effect and in power loss. Comparing to the model with the
adjustment for the data without misclassification, we will get a biased estimate for the effect of
treatment and reduced power. Therefore, statistical consideration that accounts for the existence
of misclassification should be taken in order to improve the estimate while analyzing such data.
When a covariate-adaptive randomization scheme is employed and a potentially misclassified co-
variate is included to achieve the balance, it is not clear whether it is appropriate to use the
corrected covariate, if it can be ascertained for the analysis, since the treatment is assigned based
on the misclassified variable. Intuitively, corrected data are preferred when available; however,
under Intention-to-treat (ITT) analysis, misclassified variables should be analyzed to be true to
the randomization scheme. More importantly, it is not clear if using the corrected data will impact
the validity and reliability of the trial result. It is important to understand the impact of co-
variate misclassification in the context of randomized controlled trials, especially those conducted
under covariate-adaptive randomization, where the misclassified covariate is closely related to the
treatment assignment. In trials conducted under simple randomization or in observational studies,
näıve analysis which ignores the misclassification (either via a model with misclassified covariates
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or omitting the covariate due to quality issues) may cause biased estimates of the treatment ef-
fect and power loss for corresponding hypothesis testing (Luo et al., 2012; Greenland, 1980; Flegal
et al., 1986; Reade-Christopher and Kupper, 1991; Spiegelman et al., 2000; John, 1993). In tri-
als conducted under covariate-adaptive randomization, the randomization process may have some
“add-on” effect, especially on the power and/or type I error rate, since the misclassified covariate
is involved in both the randomization procedure and the analysis.
1.2.2 Misclassification
Misclassification can be well characterized using a misclassification matrix, where each element of
the matrix represents the probability of being correctly classified or misclassified given the truth.
Suppose Xi, i = 1, 2, 3, . . . , n is the true class to which individual i belongs, where Xi has k cate-
gories with probability πj = Prob(Xi = j), j = 1, 2, 3, . . . , k and π = (π1, π2, . . . , πk−1)
T . Instead
of observing Xi, Gi is observed with certain probabilities given Xi, i.e. Olj = Prob(Gi = l|Xi =










q1,1 q1,2 · · · q1,k















where each element represents the classification probability of G , the observed value, given the true
value. When there are only two categories, q11 and q22 are usually called sensitivity and specificity,
i.e. the probability of correctly identifying true positive and true negative, respectively.
In general, there are two types of misclassification: differential and non-differential misclassification,
depending on whether or not the error probabilities change according to the level of the outcome
or the covariates. In the RCT setting, covariate misclassification is usually non-differential with
respect to the outcome, since the value of the covariate is ascertained before the outcome is observed.
However, misclassification may be differential with respect to other covariates or even the treatment
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assignment when the randomization procedure does not work well. In particular when the number
of the levels of a variable is more than 2, as in the ProTECT trial, the probabilities of being
misclassified at each level of the covariate may be different. The misclassification probabilities may
also depend on other covariates in the analysis.
1.2.3 Current methods for adjusting covariate misclassification
Many methods have been proposed to correct the bias and improve the accuracy of the estimate
for the misclassified variable itself. However, to the best of our knowledge, few methods have been
specifically developed for correcting the bias of the perfectly measured variable caused by covariate
misclassification. In addition, there is limited research focused on the performance of correcting
bias for the perfectly measured variable using methods developed for misclassified variables. The
literature review below describes the methods of bias correction for the misclassified variable.
In order to correct a misclassified covariate, additional information is needed with respect to the
mis-measured variable. This information includes: internal/external validation data, repeated
measurements or replicas and instrumental variables. Pan et al.(Pan et al., 2006, 2009) describe a
transition model to analyze data, where one of the covariates is measured with error. A transition
model assumes that, conditioning on the history of the outcome and the covariates, the distribution
of the current outcome satisfies the Markov property, i.e. the conditional distribution of the current
outcome only depends on the q prior outcomes (qth order Markov Chain). They prove that condi-
tioning on the distribution of the history of the outcome and true covariate, the joint distribution of
the current outcome and the history of the observed error-prone covariate belong to the exponential
family and therefore, sufficient statistics for the true covariate can be obtained. The estimating
equation is then constructed by summing over either the conditional score using the likelihood of
the full data or the pseudo conditional score function based on conditional density of the outcome
given the past history at each time point, which can be solved using the Newton-Raphson approach.
However, their mis-measured variable is continuous and has an additive error which is independent
of the truth and independently and identically distributed from a normal distribution with a known
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variance. Also, both the outcome and mis-measured covariate are measured at the same time and
repeatedly over time.
Other approaches described are the two stage models. In the first stage, extra information is used to
estimate the parameters for the misclassification mechanism. The estimated parameters then can
be incorporated into the analytic model as weights in the second stage. When internal/external
validation data are available, for example, Lyles et al. (2010) propose to estimate the Positive
Predictive Value (PPV) and Negative Predictive Value (NPV) via likelihood method by combining
the observed data, outcome and an educated guess of sensitivity and specificity. Then, the original
dataset is expanded using the estimated PPV and NPV as weights, which the analysis model is
built upon to estimate the coefficient of interest. Shardell et al. (2014) treat misclassification in
the missing data framework, where error-prone values are treated as missing data. After calculat-
ing a propensity score, an inverse-probability weighting method is applied for the analytic model
for standardization using the complete-data. Chen et al. (2014) propose a two-stage estimation
approach for longitudinal ordinal data with misclassification in both response and covariates based
on estimating equations. Other so-called semi-parametric methods (Schafer, 2001; Wang CY, 1997;
Roeder K, 1996) estimate parameters of the error distribution parametrically and apply nonpara-
metric methods, such as pseudo conditional likelihood, kernel function or mixture model approach
to the analytic model.
Fujisawa et al. (2000) discuss some identifiability conditions for misclassified repeated binary re-
sponses when repeated measurements or replicas of the error-prone variable are available. They
show that at least three repeated measurements are needed in order to simultaneously estimate
the misclassification parameters including false positive and false negative rates. White et al.
(2001) demonstrate the possibility of using regression calibration for error-prone categorical vari-
ables when more than two replicas are available. Li et al. (2004) propose a two stage semiparametric
Asymptotic Corrected Likelihood (ACL) estimator. The distribution of the truth is estimated by
empirical characteristic functions and truncated inverse Fourier transform (methods proposed by
Li et al. (2002), depending upon which the ACL is maximized. Wang et al. (2000) propose an
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Expected Estimating Equation (EEE) method to account for the measurement error in longitudinal
data. With misclassification, method of moments is recommended to solve for the EEE. It is also
extended to the analysis of survival data with covariate misclassification (Wang and Song, 2013)
or measurement error (Sinha and Ma, 2014). Wang et al. (1996) use quasi-likelihood models with
misclassified covariate replaced by an estimate of the calibrated expected value of the covariate
given other perfect measured variable and misclassified variable. The estimation is carried out
both using approximations and through Monte Carlo simulation.
A limitation of all these methods is that they require either assumption of a known distribution of
the underlying truth or estimation of its distribution given the observed data. None of the methods
described above for handling a misclassified covariate takes into consideration the continuous fashion
of disease progression and the ordinal nature of its assoication with the outcome at the same time
, which is a reasonable and plausible assumption to make.
1.2.4 Markov chain and Hidden Markov Model
Markov chain is a stochastic process that describes the transitions from one state to another on a
state space. It satisfies the Markov property that for a qth order Markov chain, the future state only
depends on q states that are prior to that state, but not the entire history of the previous states.
Hidden Markov models (HMMs) are built upon an unobservable process, which follow a Markov
chain. What is observed is a second stochastic process governed by the underlying unobserved
states with certain emission probabilities for each state. Given the latent state, the probability of
observing a certain state is called the emission probability. Conditioning on the underlying invisible
states, the observed states at each time points are independent, i.e. the latent process contains all
information that is needed to explain the observed behavior. Therefore, a HMM is also called a
doubly stochastic process (Rabiner, 1990). The model structure can be graphically illustrated as
following in Figure 1 (Boyer):
In the context of this research, the latent states s1, s2, . . . , st are the unobservable true disease
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Figure 1: Markov Chain
severity to which a subject belongs at time t. The observed states o1, o2, . . . , ot are the disease
severity to which the subject is assigned based on some categorized score, like NIHSS or GCS
at each time point. Therefore, the emission probabilities can be considered as the classification
probabilities: the probability that a subject is assigned to a certain severity level, given that the
subject truly belongs to a specified severity level, i.e. Prob(ot = l|st = j), l, j = 1, 2, . . . , k, where
k is the total number of levels for which the score is categorized.
There are two general forms of the HMM: discrete and continuous time hidden Markov model
(DTHMM and CTHMM). DTHMM is considered as the traditional approach to HMM. For DTHMM,
the Markov chain is characterized by transition probabilities between hidden states, where the ob-
servation times are equally spaced steps and may not be closely relevant . For example, in speech
recognition(Rabiner and Juang, 1993; Jelinek, 1997) or biological sequence analysis (Yoon, 2009),
DTHMM is a good fit since switching between pronunciations or different functional region on a
DNA sequence is observed exactly, thus the DHMM model is widely applied to analyze such data.
CTHMM assumes the Markov chain is in a continuous-time fashion and is characterized by tran-
sition intensity between hidden states, i.e. the instantaneous transition probabilities. CTHMM is
more suitable in medical research, in that disease progression itself is continuous, while the eval-
uation or observation of disease status is usually irregularly spaced. The exact transition time
between states may not be observable, except for absorbing states like death. The application of
CTHMM in describing disease progression can be found in the literature (Sweeting et al., 2006;
Buter et al., 2008; Terrault et al., 2008; Mayet et al., 2012; Jackson and Sharples, 2002).
Another important advantage of using HMMs is that they automatically account for the potential
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misclassification of the observed data, since they simultaneously model the transition between the
underlying states and the emission probabilities given the underlying truth. In the presence of mis-
classification, the emission probabilities can be interpreted as misclassification probabilities(Jackson
et al., 2003). Therefore, HMMs provide a convenient framework to estimate the misclassification
probabilities by modeling the repeatedly measured error prone variable, while taking into consid-
eration the time varying effect of the covariate. Bureau et al. (2003) apply CTHMM to study
misclassified disease outcomes with two examples: the oral lesion hairy leukoplakia and cervical
human papillomavirus (HPV) infection. The Markov property and the independence assumption
allow simultaneous estimation of all possible transitions between disease states together with the
probabilities of being misclassified. The structure of the resulting model is relatively simple. In
addition, they also proposed a modification that can be used to include covariates in the model,
thus providing a more flexible way to address different misclassification assumptions. However, the
model goodness of fit and Markov property need to be assessed using diagnostic techniques. Jack-
son et al. (2003) also present a multistate Markov model for disease progression with the states of
the disease subject to misclassification. The model is used to simultaneously estimate the sensitiv-
ity and specificity of ultrasonography screening for aortic aneurysm as well as the progression rate
between latent stages. They also point out that pre-specifying the initial conditions of a Markov
process was very important in order to get accurate estimation, which would be the starting value
of the probability that underlying states occupied in the misclassification case . Van Den Hout et al.
(2009) fit a three-state CTHMM to estimate life expectancy in health and ill health, with allowed
misclassification in the observed improvement of cognitive ability. Gangnon et al. (2014) also apply
CTHMM to investigate the impact of misclassification of age-related macular degeneration on the
baseline intensity. After accounting for misclassification, the regression of the disease is rare, which
is different from previous results reported in the literature.
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1.2.5 Misclassification Simulation-Extrapolation Method (MC-SIMEX)
Misclassification Simulation-Extrapolation Model was an extension of the Simulation-Extrapolation
(SIMEX) method for measurement of error model(Kuchenhoff et al., 2006). The SIMEX model was
first introduced by Cook and Stefanski (1994). It was a simulation based method of inference which
was simple to implement especially for fitting generalized linear models. The basic idea for this
method is that by adding an extra known increment of error to the data, the pattern or trend of
change in the estimation can be demonstrated. Then, the inference in the case of no measurement
error can be obtained by extrapolating this trend back. One requirement for this method is that the
trend of change is in general monotone convex or concave in order to get conservative corrections
using best linear-tangential approximations. In 2006, Kuchenhoff, Mwalili and Lesaffre (Kuchenhoff
et al., 2006) introduced the MCSIMEX model by extending the SIMEX method, which is a general
regression method that deals with misclassification cases. It can be applied to misclassification of
the outcome, predictors or both.
For the MCSIMEX model, a pre-specified misclassification matrix is needed in order to characterize
the misclassification error and simulate the pseudo contaminant data sets as in the SIMEX method.
The misclassification matrix is first factorized based on the diagonal matrix of eigenvalues and
corresponding matrix of eigenvectors. Then the extra increment of the error is added with a
fixed grid of values (integers such as 1, 2, . . . , n), raising to the power to the diagonal matrix of
the eigenvalues. In the simulation step, for each increment of the error, B new pseudo data sets
are simulated using the misclassification matrix with the additional error. The estimate of the
coefficients in the model is then an average over those obtained based on the B pseudo data sets.
In the extrapolation step, a parametric model is fit on the estimated coefficients obtained in the
simulation step and the fixed grid of values by least squares. The forms of the extrapolation
function (parametric model) can be linear, quadratic, exponential, or log-linear functions, with the
quadratic extrapolation function performing the best in most cases.
According to their simulation results, the MCSIMEX method performs better than simple matrix
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method with respect to the coverage probabilities for the parameter of error-prone variable, although
they show similar bias correction abilities. Compared to the maximum likelihood method, the
MCSIMEX model does not perform as well. However, due to its ease of implementation and
flexibility of dealing with more complicated modeling, as well as its comparable ability for bias
reduction and good coverage probability, it is still suggested to use the MCSIMEX model when
applicable.
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Abstract
Under covariate adaptive randomization, the covariate is tied to both randomization and
analysis. Misclassification of such covariate will impact the intended treatment assignment;
further, it is unclear what the appropriate analysis strategy should be. We explore the impact
of such misclassification on the trial’s statistical operating characteristics. Simulation scenarios
were created based on the misclassification rate and the covariate effect on the outcome. Mod-
els including unadjusted, adjusted for the misclassified, or adjusted for the corrected covariate,
were compared using logistic regression for a binary outcome and Poisson regression for a count
outcome. For the binary outcome using logistic regression, type I error can be maintained in the
adjusted model but the test is conservative using an unadjusted model. Power decreased with
both increasing covariate effect on the outcome as well as the misclassification rate. Treatment
effect estimates were biased towards the null for both the misclassified and unadjusted models.
For the count outcome using a Poisson model, covariate misclassification led to inflated type
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I error probabilities and reduced power in the misclassified and the unadjusted model. The
impact of covariate misclassification under covariate-adaptive randomization differs depending
on the underlying distribution of the outcome.




The randomized controlled trial (RCT) is considered the gold standard for valid inference regarding
the efficacy of an intervention. One of the key elements of an RCT is its randomization procedure
which assures the validity and generalizability of the trial’s results. Simple randomization is of-
ten used due to its ease of implementation; however, large imbalance in baseline covariates across
treatment arms may result, especially when sample size is not sufficiently large. Covariate-adaptive
randomization has been frequently used in order to control the imbalance(Thall and Wathen, 2005;
Krag et al., 2010; Atagi et al., 2012; Sherrington et al., 2014; Ellis et al., 2014; Ybarra et al., 2013;
Ersek et al., 2012; Weir and Lees, 2003).A trial well-balanced on prognostic covariates is more pow-
erful in the comparison of the treatment effect and yield a more convincing result (Kundt, 2009).
It will also increase the power for subgroup analyses (Toorawa et al., 2009), since it balances the
treatment arms among subjects with a given factor. However, under covariate adaptive randomiza-
tion, the intended type I error rate can be maintained only when the model is correctly specified,
which means that all covariates included in the randomization procedure are also included in the
analytic model (Hu and Hu, 2012; Shao and Yu, 2013).
Unfortunately, covariates are sometimes measured with error, and in the case of categorical covari-
ates, we consider these subjects to be misclassified. The rate of misclassification may vary from
trial to trial and from covariate to covariate. For example, according to the review of Data and
Safety Monitoring Board, in the Interventional Management of Stroke (IMS) III trial (Broderick,
2013), about 2% of subjects with severe stroke were misclassified as having a moderate stroke, and
similarly about 2% of subjects with moderate stroke were misclassified as having a severe stroke at
the time of randomization. In the Progesterone for Traumatic Brain Injury: Experimental Clinical
Treatment (ProTECT III) trial, 13.8% of the subjects with most severe traumatic brain injury
(TBI) were misclassified as having a moderate to severe TBI; 7% and 3% of moderate severe TBI
were misclassified as having a most severe and moderate TBI, respectively; 1% and 14% of moderate
TBI were misclassified as most severe and moderate severe TBI.
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Under the covariate-adaptive randomization scheme, the treatment assignment is tied to the mis-
classified covariate; as a result, it is not clear whether the analysis should be based on the mis-
classified covariate information or the corrected data. Intuitively, corrected values are preferred
when available; however, under intention-to-treat (ITT) analysis, misclassified variables should be
analyzed in order to remain true to the randomization scheme. Näıve analysis which ignores the
misclassification (either via a model with misclassified covariates or without adjustment) may cause
biased estimates of the treatment effect, which may directly impact the power of the trial, as well as
its validity and reliability (Luo et al., 2012; Greenland, 1980; Flegal et al., 1986; Reade-Christopher
and Kupper, 1991; Spiegelman et al., 2000; John, 1993). Moreover, unlike simple randomization,
covariate-adaptive randomization may have some “add-on” effect, especially on the power and/or
type I error. Therefore, it is important to understand the impact of misclassification errors in the
context of RCTs, where the power, type I error and bias in the treatment effect are important
components to the success of a trial.
With classic linear regression, if the covariate is only correlated with the outcome but not the
treatment, an unbiased estimate for treatment effect can always be obtained whether or not that
covariate is included in the model (Robinson and Jewell, 1991). Therefore, covariate misclassi-
fication will not impact the point estimate of the treatment effect but will reduce the power of
hypothesis testing for the treatment effect. Under the generalized linear regression frame work,
where the outcomes have an underlying binomial or Poisson distribution, the impact of covariate
adjustment is different (Robinson and Jewell, 1991). For a binary outcome with logistic regression,
if the true outcome distribution is conditioned on the covariate (i.e. there is covariate effect on
the outcome), failure to adjust for the covariate results in a biased estimate for the treatment
effect (Robinson and Jewell, 1991; Gail et al., 1984). On the other hand, inclusion of the covariate
increases the variance of the estimate for the treatment effect. That is, adjusting for a prognostic
covariate will reduce the precision of the treatment effect estimate, but still results in power gain
for the test of treatment in terms of the asymptotic relative efficiency (Robinson and Jewell, 1991).
Given the above impact of covariate adjustment in both randomization and analysis, it is necessary
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to explore the influence of covariate misclassification on type I error, power and estimation bias
for the treatment effect under covariate-adaptive randomization. In this paper, we investigate this
impact, with a focus on analysis via generalized linear regression models in the scenario where the
true covariate value is available at the time of the analysis. We provide the results of a simulation
study conducted under covariate-adaptive randomization. Section 2 provides a theoretical expla-
nation for the simulation result. The simulation methods are described in Section 3 and the results
shown and explained in Section 4. We provide the conclusion and discussion about the impact in
practice and some recommendations in the last section.
2.2 The validity of the tests when covariate is misclassified
2.2.1 Outcome with underlying binomial distribution
Shao et al. (2013) has shown that under covariate-adaptive randomization, the nominal level of
the test will be maintained only when the covariates are adjusted for in the analysis; the test
without covariates is conservative unless there is no covariate effect on the outcome. When the
covariate adjusted for is misclassified, the nominal level of the test will still be maintained. To
show this, suppose a pooled table and sub-tables are set up as in Table 1; where Y , Z, X and G
represent outcome, treatment assignment, true covariate and misclassified covariate respectively.
The prevalence of the covariate in the data is m, i.e.Prob(X = 1) = m .
Table 1: Expected cell frequencies for pooled and sub-tables
Pooled Table Sub-table X = 1 Sub-table X = 0
Y = 1 Y = 0 Total Y = 1 Y = 0 Total Y = 1 Y = 0 Total
Z = 1 a b N1 Z = 1 a1 b1 N1m Z = 1 a0 b0 N1(1−m)
Z = 0 c d N0 Z = 0 c1 d1 N0m Z = 0 c0 d0 N0(1−m)
Assume the misclassification probabilities ki, i = 0, 1 are non-differential with respect to the out-
come Y , i.e.Prob(G = 1|X = 0) = k0, P rob(G = 0|X = 1) = k1. Then the resulting expected cell
frequencies for the sub-tables stratified by the misclassified covariate G are in Table 2.
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Table 2: Expected cell frequencies for sub-tables by misclassified covariate
Sub-table G = 1 Sub-table G = 0
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Under the null distribution where there is no treatment effect, given X = 1, the probabilities in








= t, where t is
the constant ratio between a1 and c1,as well as N1 and N0.Then a1 and N1 can be expressed as
a1 = tc1 and N1 = tN0. The ratio between a0 and c0 equals to t as well because given X = 0,








= t. When there is misclassification
as in Table 2, the probability of Y = 1 can be expressed as:
Prob(Y = 1|G = 1, Z = 1) =
a1(1− k1) + a0k0
N1m(1− k1) +N1(1−m)k0
(3)
Prob(Y = 1|G = 1, Z = 0) =
c1(1− k1) + c0k0
N0m(1− k1) +N0(1−m)k0
(4)
Using the ratio notation defined above, then (3) becomes
Prob(Y = 1|G = 1, Z = 1)
=
tc1(1− k1) + tc0k0
tN0m(1− k1) + tN0(1−m)k0
=
c1(1− k1) + c0k0
N0m(1− k1) +N0(1−m)k0
= Prob(Y = 1|G = 1, Z = 0)
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That is, although the proportion of Y = 1 is altered by the misclassification process from (1) to (3),
the magnitude of the change is the same across treatment arms under the null distribution. Thus, if
there is no treatment effect given the true covariate value X = 1, there is no treatment effect given
the misclassified covariate G = 1. The same approach can be used to demonstrate the impact given
X = 0 and G = 0. Therefore, the type I error probability is not affected by the misclassification,
regardless of whether adjustment is made for the true covariate or the misclassified covariate.
2.2.2 Outcome with underlying Poisson distribution
The asymptotic property of the Poisson log-linear regression models was also developed by Shao
et al. (2013). With the quasi-Poisson regression models, the estimated variability of the outcome
based on the unadjusted model then becomes ϕE(Yij), where ϕ is the estimated over-dispersion
parameter and is greater than 1 if the data are over-dispersed. Therefore, an extension to the
equation in Shao et al. becomes:





which reduces to 2Φ(−Cαϕ), and the test is conservative in the unadjusted model of quasi-Poisson
regression under covariate-adaptive randomization. However, the estimated over-dispersion param-
eter in a naive model of quasi-Poisson regression will depend on the amount of misclassification in
G, the misclassified covariate. And the overall variability could be estimated correctly. Thus the
type I error could be maintained. The same rationale works for the negative binomial regression
model.
2.3 Simulation scenarios and hypothesis testing
Suppose a randomized controlled trial is going to be carried out with a goal of detecting an absolute
10% difference in a favorable outcome, with a 40% success rate assumed in the control group. This
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yields an unadjusted odds ratio of 1.5 for the treatment effect. A sample size of 1,000 (500 subjects
per group) is estimated in order to obtain 90% power to detect this unadjusted effect at a 5%
significance level. This is similar to the assumptions specified in the IMS III trial design (Broderick,
2013). For each scenario described below, 10,000 trials are simulated using Monte Carlo simulation
method. The operating characteristics – type I error, power and bias with respect to the treatment
effect – are compared between simple randomization and covariate-adaptive randomization.
In each trial, there are three variables of primary interest: Z is a dichotomous treatment assignment,
X is a prognostic covariate which is dichotomous and subject to misclassification, and Y is the
outcome of interest. We assume Z is perfectly measured (i.e., recorded without error). We also
assume that the misclassification error of X is non-differential with respect to the treatment and
the covariate itself, i.e. the misclassification probabilities are the same for both treatment arms as
well as at both levels of the covariate. No interaction between the treatment effect and the covariate
is considered. Dichotomized variables X and Z are generated from a Bernoulli distribution with
p = 0.5, i.e. Prob(X = 1) = Prob(X = 0) = Prob(Z = 1) = Prob(Z = 0) = 0.5. A misclassified
version of X, denoted as G, is also generated, with the same misclassification rates for each level
of X (i.e. Prob(G = 1|X = 0) = Prob(G = 0|X = 1)), varying from 0 to 40%. Under simple
randomization, X (as well as G) and Z are generated independently, while under covariate-adaptive
randomization, Z is generated within each level of G, the misclassified version of the covariate.
Both permuted block randomization and biased-coin randomization are incorporated for covariate-
adaptive randomization. Based on published recommendations, the block size for permuted block
randomization is set at 4 (Efron, 1971; Matts and Lachin, 1988) and the probability assigned to
the biased-coin is 0.85 (Smith, 1984; Zelen, 1974).
We investigate two different types of outcome, binary and count data, both of which are analyzed
using generalized linear regression models. For the dichotomous outcome, the response variable Y
is generated from a Bernoulli distribution; when the outcome represents count data, the response
variable Y is generated from a Poisson distribution. In both cases, the linear combination of X(the
correct version of the covariate), Z(treatment assignment), and their corresponding prespecified
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coefficients are used to define the distributional parameters: the probability for the Bernoulli dis-
tribution and the rate for the Poisson distribution. For both outcomes, the beta coefficient for Z
is fixed at 0.405 under all scenarios. This is equivalent to either an unadjusted OR of 1.5 or rate
ratio of 1.5 between treatment groups. For logistic regression, the coefficient for X also varies from
-3 to +3, which results in a wide range of X effects on Y on the scale of odds ratio (ranged from
0.064 to 23.2). For Poisson log-linear regression, the coefficient for X is fixed at 1.6 (rate ratio =
4.95) with varying misclassification rate.
Hypothesis testing for the effect of treatment Z is based on three analysis approaches (described
below) applied to the simulated data. All models include treatment Z. Model (5) is the true
model, adjusting for the corrected version of the covariate X. Model (6) is the misclassified model,
adjusting for the misclassified covariate G. Model (7) is the unadjusted model including only
treatment Z:
g1(p) = βx0 + βxzZ + βxX (5)
g2(p) = βg0 + βgzZ + βgG (6)
g3(p) = β0 + βzZ (7)
In each model, g(p) is the link function – logit when Y is binary or log when Y is count; p is the
parameter for the distribution, either Prob(Y = 1|·) or Pois(λ|·). For count data, in addition to
the Poisson log-linear regression, quasi-Poisson and negative binomial regression are also considered
given the potential in practice for over-dispersion.
2.4 Simulation study
Figures 2 – 8 show the results under simple randomization (Panel A) and that under covariate-
adaptive randomization (Panel B). We only present the results under stratified permuted block
randomization for covariate-adaptive randomization, because the results are similar under stratified
permuted block randomization and stratified biased coin randomization. Supplemental Tables 3 –
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5 provide detailed numerical examples with pre-specified coefficients describing and comparing the
change pattern for type I error, power and bias. Throughout the simulation, the bias is defined as
the difference between the estimated beta coefficient and 0.405, the true parameter value.
2.4.1 Dichotomized outcome: logistic regression with logit link
The operating characteristics for each model are presented as follows: the true model (Model (5))
is represented in red, the misclassified or naive model (Model (6)) is represented in blue, and the
unadjusted model (Model (7)) is represented in black.
2.4.1.1 Under simple randomization Under simple randomization, where covariate informa-
tion is not adjusted for during the randomization process, misclassification impacts the hypothesis
testing and parameter estimation only through covariate adjustment in the analysis. The type I
error is maintained in all three models (Figure 2, Panel A). The true model has the smallest power
loss, while the unadjusted model has maximum power loss (Figure 3, Panel A). The power loss
of the misclassified model depends on the misclassification rate, as well as the magnitude of the
effect of covariate X on the outcome Y . With increasing rate of misclassification or increasing
magnitude of the effect of covariate X, the amount of power loss increases. As expected based
on the literature (John, 1993; Gail et al., 1984), the estimated beta coefficient of treatment Z is
biased towards the null in the unadjusted model, while the estimate in the true model is unbiased
(Figure 4, Panel A). The direction of the bias caused by misclassification in the misclassified model
is the same as that caused by failing to adjust, and is towards the null. The magnitude of this bias
in the adjusted misclassified model increases with increasing misclassification rates as well as with
increasing absolute magnitude of βx, the covariate effect.
2.4.1.2 Under covariate-adaptive randomization Under covariate-adaptive randomization,
information from covariate G is adjusted for during the randomization. Either X or G is adjusted
for in the final analytic model. Hypothesis testing for the treatment effect is conservative using
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the unadjusted model, while both the misclassified model and the true model preserve the nominal
type I error (Figure 2, Panel B). With increasing misclassification rate, the type I error of the
unadjusted model approaches the nominal level.
The impact of covariate misclassification on power under covariate-adaptive randomization is the
same as that under simple randomization (Figure 3) with respect to both the pattern and magnitude
of the impact. The true models have the smallest power loss under all scenarios. The magnitude
of power loss is not trivial using the unadjusted model when the covariate effect is large relative to
the treatment effect. The power loss caused by adjusting for the misclassified covariate depends on
both the magnitude of the covariate effect as well as the misclassification rate, similar to what is
observed for simple randomization. For example, when βx = −2.0 and βz = 0.405, the power of the
true model is about 80%, while the power of the unadjusted model is only 70%, although the study
is designed to have 90% power. The power for the misclassified model is in between that of the true
model and the unadjusted model. A direct comparison between simple randomization and covariate-
adaptive randomization can be seen in the supplementary document (Figure ??). The resulting
power for the unadjusted/misclassified/true model under covariate-adaptive randomization is very
close to each of those under simple randomization.
Also, the pattern in the changes in the bias under covariate-adaptive randomization was similar to
that under simple randomization (Figure 4). The maximum bias was observed in the unadjusted
model; with approximately 10% misclassification, the bias observed in the misclassified model was
about a half of what was observed in the unadjusted model. At higher rates of misclassification
(30% or higher), adjusting for a misclassified covariate was similar to not adjusting for the covariate























































































































































































































































































































































































































































































































































































































































2.4.2 Count of events as outcome: Poisson, quasi-Poisson and negative binomial re-
gression with log link.
For the simulated count data, we fit 3 sets of log-linear regression models: Poisson regression,
quasi-Poisson regression and negative binomial regression. Each set of regression models includes
an unadjusted model, a model adjusted for the misclassified covariate and a model adjusted for the
corrected covariate.
With Poisson regression (Figure 6 – 8, solid lines), under simple randomization the type I error
(Figure 6, Panel A) is maintained only in the true model (red line). Both the unadjusted (black line)
and misclassified (blue line) models have inflated type I error probabilities, with the magnitude of
inflation increasing with increasing misclassification rate in the misclassified model, and maximized
in the unadjusted model. Pre-specified power (Figure 7, Panel A) is obtained using the true model
only. The unadjusted model has the maximum power loss, and the power loss observed in the
misclassified model increases with increasing misclassification rate. No bias (Figure 8, Panel A)
is observed for the estimate of the treatment effect in any of three models. Under covariate-
adaptive randomization, the true model (red line) maintained the type I error (Figure 6, Panel
B) at the nominal level. In data with no misclassification, the type I error is also maintained in
the unadjusted model (black line). However, with increasing misclassification rate, type I error
probabilities are inflated in both the unadjusted (black line) and misclassified (blue line) models
with a similar magnitude. The loss in power under covariate-adaptive randomization (Figure 7,
Panel B) is similar to that under simple randomization. Bias is neglegible for all three models
(Figure 8, Panel B).
Quasi-Poisson regression and negative binomial regression behave similarly to each other. To better
demonstrate graphically, only results of quasi-Poisson regression are shown in Figure 6 – 8 (dashed
lines). While use of the quasi-Poisson or negative binomial regression captures the over-dispersion
described earlier, the target power is maintained only by the true model. In fact, failure to adjust
is associated with an even larger power reduction for these over-dispersed models than for the
Figure 5: Estimated overdispersion parameter for quasi-Poisson model
typical Poisson regression model. As previously demonstrated, the magnitude of power loss in the
misclassified models depends on the misclassification rate. Under simple randomization (Figure
6, Panel A), all models maintain the nominal type I error. However, using the unadjusted quasi-
Poisson (green line) or negative binomial regression model (result not shown), more significant
power loss than that of the unadjusted Poisson regression model (black line) is identified. The
magnitude of power loss in the misclassified models (purple line) depends on the misclassification
rate. Under covariate-adaptive randomization (Figure 6, Panel B), both of the adjusted models
with either the true covariate (orange line) or the misclassified covariate (purple line) maintains type
I error, while the unadjusted models are conservative. The misclassified models again demonstrate
substantial power loss (almost doubled) compared to that of the misclassified Poisson model (blue
solid line). The estimated dispersion parameter increases in the misclassified model (Figure 5) as
well, where the estimated dispersion parameter is maximized in the unadjusted model and fixed,
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2.5 Conclusions and discussion
When the misclassification rate is high, covariate-adaptive randomization performs more like sim-
ple randomization. With increasing misclassification rate, especially when the misclassification
rate is relatively large (e.g. 40%), the covariates are not informative during the covariate-adaptive
randomization process. Under simple randomization, where the covariate is not involved during
randomization procedure, covariate misclassification will only cause power loss and biased estima-
tion through analytic models, and this result is consistent with the literature (Greenland, 1980;
John, 1993; Robinson and Jewell, 1991). However, the results under covariate-adaptive randomiza-
tion indicate that the impact of the randomization scheme depends on the underlying distribution
of the outcome.
For binary outcome with logistic regression, covariate-adaptive randomization does not have an
additive effect on bias and power loss caused by covariate misclassification, even when the misclas-
sified covariate is adjusted for in the randomization procedure and in the model. While the type I
error probability can be maintained through adjustment for the misclassified covariate, the resulting
power is less than targeted, whereas adjustment for the corrected covariate will minimize the power
loss and maintain nominal type I error probability. The bias of the estimate for the treatment effect
has the same direction in the misclassified model as that in the unadjusted model, with a smaller
magnitude in the misclassified model. The magnitude of the bias depends on the misclassification
rate as well as the effect of the covariate on the outcome. The amount of bias and power loss is
not trivial, especially when the covariate effect on the outcome is relatively large compared to the
treatment effect. The operating characteristics of misclassified models are more similar to that of
the unadjusted models as the misclassification rate increases. The results presented pertain to the
scenario where the covariate prevalence is 50% (i.e. Prob(X = 0) = Prob(X = 1)). Additional
simulations (results presented in the supplementary document, Figure 10) demonstrate that, for
a given covariate effect and misclassification rate, the effect of the misclassification on the power
and the bias is slightly lessened when the covariate prevalence is away from 50%, but the pat-
tern remains the same. This is likely because the variability in the covariate is maximized when
the prevalence is 50%. When the prevalence is much larger than 50%, the information gained by
inclusion of the covariate is reduced, as is the noise introduced by the misclassification.
For count of events with Poisson regression, on the other hand, the randomization scheme does
have additional influence on power and type I error. No bias is observed using either an adjusted or
unadjusted model under either randomization scheme. This is consistent with the finding by John
et al. (1993) and Gail et al. (1984). Under simple randomization, the magnitude of power loss and
type I error inflation is maximized in the unadjusted model regardless of covariate misclassification,
but increases with increasing misclassification rates in the misclassified model. However, under
covariate-adaptive randomization, the operating characteristics of the misclassified model and the
unadjusted model are similar, where power loss and type I error rate inflation in both models
depends on the rate of misclassification.
Due to misclassification, only part of the variability of the covariate is accounted for through the
randomization procedure. With either the unadjusted model which excludes the covariate or the
misclassified model, the “residual” variability due to the covariate results in over-dispersion. This
over-dispersion will not be estimated correctly using Poisson regression since the estimated variance
is assumed to be equal to the expected count. Thus under covariate-adaptive randomization, with
Poisson regression, the variability for the outcome in an unadjusted model or misclassified model
will be underestimated with the amount depending on the misclassification rate. As a result,
power is reduced and type I error is inflated. Quasi-Poisson and negative binomial models are
very often used for data with anticipated over-dispersion. Given the flexibility to estimate the
variance differently from the expected count in these two models, the variability in the covariate,
which is not sufficiently accounted for because of covariate misclassification during randomization,
can be estimated through the adjusted model. However, with the unadjusted model, where no
information about the covariate is included in the model, the amount of “residual” variability can’t
be accurately estimated. Instead, the unadjusted quasi-Poisson and negative binomial models will
be estimating over-dispersion, which does not truly exist (or at least partly) since the variability
(or part of the variability) of the covariate is eliminated under covariate-adaptive randomization.
The work described herein assumes that the true value of the prognostic covariate is observable,
which is not always the case. The main purpose is to show how misclassification in the covariates
affects the estimation of the treatment effect. The results remain relevant when the truth is not
observable, although the manner in which such misclassification would be identified and corrected is
left as a topic for future work. One limitation of this work is that we only considered non-differential
misclassification of the covariate with respect to treatment assignment; differential misclassification
may have more complicated impact on the treatment effect estimation if the treatment effect itself
is expected to vary according to the covariate. In addition, we only investigated two types of
covariate-adaptive randomization, other randomization algorithms may also be considered in the
future.
Overall, adjustment for the covariate is always recommended in the final analysis even when the
quality of the covariate is questionable. Effort should be made to identify potential misclassification
and adjust for the corrected covariate in the analysis in order to minimize power loss and to more
accurately estimate the treatment effect. On the other hand, given the fact that the effect of
prognostic covariates on the outcome reported in the literature varies, statistical methods, and
perhaps sample size reassessment, should be considered to correct the bias in estimating treatment
effect if there is anticipated or observed covariate misclassification.
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_ĉ _d̂ _ef _^
g h i j k l m n o p j  
q r s t u v w x
y z{|}
Y Z Y [ Y \ ] \ [ Z^ _`̂ _â _b̂
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Figure 9: Direct comparison of power between simple randomization and covariate-adaptive randomization
Figure 10: Impact of covariate misclassification on power and bias with varying covariate prevalence.
The misclassification probabilities are fixed at 20% for both levels of the covariate. The crude covariate effect on
the outcome in terms of Odds Ratio is 4.95. The X-axis represents varying prevalence of the true covariate, i.e.
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Abstract
In medical research, many diseases are characterized by discrete states although the transi-
tion between the states is continuous. The evaluation of the disease states are sometimes subject
to misclassification due to either patient’s characteristics which interfere with the accuracy of
the assessment or the sensitivity of diagnostic tests. In addition, patient’s evaluation schedule
is usually pre-specified resulting in panel-observed data. Applications of the continuous time
Hidden Markov Model (CTHMM) for data with misclassification have been proposed in the
literature. However, model performance, in terms of estimation and model diagnosis, is not
well described. We provide a simulation study to demonstrate the performance of the model
with a focus on misclassification. We also propose an alternative AIC based approach derived
according to modified full data likelihood to directly compare CTHMM and basic Markov Model
in order to identify the misclassification error in the data. Simulation scenarios were generated
with varying parameters including transition intensities, misclassification probabilities, number
of observations per subject, and sample size. Results based on both basic Markov Model (MM)
and CTHMM were compared. The performance of our proposed AIC based approach was also
compared to the Pearson type goodness-of-fit test in terms of identifying a correct model for
the data. For a two-state CTHMM, the performance of the model in terms of point estimate
and model goodness-of-fit highly depends on the size of transition intensity relative to the ob-
servation schedule and the amount of misclassification in the data. Increasing total sample
size, increasing number of observations per subject, and increasing variability in the observation
schedule improves the performance. The CTHMM can be used to estimate the misclassification
probabilities in the data. The proposed AIC based approach can identify the correct model for
data with or without misclassification.
Keywords:CTHMM, misclassification, AIC, model diagnosis
3.1 Introduction
In medical research, a patient’s condition is often categorized into one of several finite disease states
(eg, mild, moderate, or severe) based on lab results, clinical assessments, or physical examinations.
However, such evaluation is sometimes easily confounded and may result in misclassification due
to either patient or examiner characteristics that interfere with the accuracy of the assessment or
the sensitivity of the diagnostic test used for evaluation. Naive analysis of the data assuming no
misclassification error will lead to biased estimates, resulting in misleading conclusions (Fan et al.,
2015). Multistate models (MSM) have been widely used for longitudinal categorical data and are
useful tools to model disease dynamics when the disease is characterized into states. However, the
transition of the disease from one state to another may not be observed exactly. In clinical trials,
the timing of follow-up visits is often determined by the protocol rather than by the occurrence
of an event; this results in panel-observed data, where the transition occurs between the current
assessment and the previous assessment. A continuous-time hidden Markov model (CTHMM)
relates the true disease condition to the transition of the latent status, which follows a continuous-
time Markov chain (Bureau et al., 2003; Jackson et al., 2003). Conditional on the underlying true
disease status, the observed data can be characterized via the emission probabilities. The structure
of the CTHMM provides a convenient framework to simultaneously estimate the disease dynamics
and the potential probability of data misclassification. Such applications have been proposed in
the literature (Bureau et al., 2003; Jackson et al., 2003; Jackson and Sharples, 2002) and applied
in different disease areas including cognitive decline and dementia (Marioni et al., 2012; Norton
et al., 2013; Buter et al., 2008), HIV/HPV (Human Papilloma Virus) infection (Blitz et al., 2013),
as well as liver cirrhosis and hepatitis C (Bartolomeo et al., 2011; Terrault et al., 2008; Sweeting
et al., 2006).
Despite the use of the CTHMM in clinical applications, the evaluation of the CTHMM’s perfor-
mance in the case of misclassification is limited. Rosychuk et al. (Rosychuk and Thompson, 2003;
Rosychuk and Islam, 2009; Rosychuk RJ, 2004) discussed the impact of misclassification on the
accuracy of transition probability estimates for an alternating binary Markov disease process. How-
ever, they only investigated equally spaced observations with small misclassification. Other authors
(Leroux, 1992; Petrie, 1969; Baum and Petrie, 1966) have studied the identifiability issue for hidden
Markov model without addressing the impact of misclassification on the performance. In addition,
as recommended in the literature (Bureau et al., 2003), comparing the estimated transition inten-
sity with and without the latent structure is a useful initial step to evaluate the goodness-of-fit
of the hidden Markov model. Aguirre-Hernandez and Farewell (Aguirre-Hernandez and Farewell,
2002) originally proposed using the Pearson-type goodness-of-fit test to evaluate the model fit,
and Titman and Sharples (Titman and Sharples, 2008) extended it to the case of misclassification.
However, the performance of the test has not been well studied and may potentially suffer from
power due to grouping the time intervals and from other model assumptions (Titman and Sharples,
2008).
The purpose of this paper is to investigate the performance of the CTHMMwith a focus on misclassi-
fication with respect to both the point estimates and model goodness-of-fit. We expand Rosychunk
et al.’s simulation to more sophisticated scenarios in order to fully examine the performance of
CTHMM with a focus on misclassification. We also propose an AIC based approach based on the
modified full data likelihood to directly compare Markov models with and without the latent struc-
tures (i.e. the hidden Markov vs. basic Markov model) and compare the performance to that of the
modified Pearson-type goodness-of-fit test. The rest of the paper will be organized as follows. In
section 2, the CTHMM will be introduced in detail, including assumptions, notation, the algorithm
for estimation, and model diagnostics. The simulation used to evaluate the performance of the
model will be described and the results will be presented in section 3. Section 4 will introduce the
proposed modified full data likelihood and AIC, and demonstrate its performance through Monte
Carlo simulation. Finally, we will close the paper with discussion and recommendations based on
the simulation results.
3.2 Continuous-time hidden Markov model (CTHMM)
3.2.1 Model setup and likelihood for CTHMM
Consider a two-state CTHMM for alternating binary longitudinal outcomes, as described by (Bu-
reau et al., 2003; Jackson et al., 2003; Rosychuk and Thompson, 2003). LetO = {O(t1), O(t2), . . . , O(tm)}
represent m observed states with state space {0, 1} for individual subject. The observed states:
O(t1), O(tt2), . . . , O(tm) are independent given their underlying true states, denoted as S = {S(t1), S(t2), . . . , S(tm)}
where the underlying latent states S are assumed to follow a first-order continuous-time Markov
process with the same state space {0, 1}. That is, given the current state at time tm(S
(tm)), the
future state (S(tm+1)) is independent of the past state (S(T<tm)). Let ∆tm = tm+1 − tm denotes
the time interval between the current and the future observation. The continuous-time indicates
that the probability of transition out of the current state depends on the time (∆tm) spent in that
state. Then Pij{∆tm}, the probability of transitioning from state i at time tm to state j at time
tm+1 with interval time ∆tm, can be expressed as:
Pij{∆tm} = P{S
(tm+1) = j|S(tm) = i, S(T<tm) = s} = P{S(tm+1) = j|S(tm) = i}
The latent process is described by the instantaneous transition rate from one state to another,
referred to as transition intensities. For a homogeneous continuous-time Markov process, these
intensities are the same over time. The transition intensities can be expressed in a matrix form Λ










where λij = lim∆t→0
prob{S(tm+1)=j|S(tm)=l}
∆t , and the mean time spent on a state before moving out
is referred to as the mean sojourn time, which can then be calculated as 1/λ01 and 1/λ10 for state
0 and 1 respectively. The transition probability between two time points with interval time ∆tm,
given the state status, is the corresponding entry in the exponentiation of the transition intensity
matrix
P (∆tm) = e
∆tmΛ
where the (i, j)th entry represents the probability of transitioning from state i to state j after
interval time ∆tm. For the two-state case, the transition probability can be calculated analytically
as,
P01(∆tm) = P (S
(tm+1) = 1|S(tm) = 0) = λ01
λ01+λ10
{1− e−∆tm(λ01+λ10)}
P10(∆tm) = P (S
(tm+1) = 0|S(tm) = 1) = λ10
λ01+λ10
{1− e−∆tm(λ01+λ10)}
The emission probabilities are the conditional probabilities of the observed states given the latent
states, i.e. πo|s = p(O = i|S = j), i, j = 0, 1 with the initial distribution probabilities for the
latent states π(s) = p(S(t1) = s), s = 0, 1. Based on all the above parameters, the likelihood of the
observed data can be expressed as:





















The latent states S(t1), S(t2), . . . , S(tm) are the unobservable true disease severity that a subject
belongs to at time (t1, t2, . . . , tm). The observed states O
(t1), O(t2), . . . , O(tm) represent the disease
severity to which the subject is assigned and is subject to misclassification error. Then the emission
probabilities πo|s can be considered as the classification probabilities, which are assumed to be the
same over time in this study.
To solve the likelihood, the expectation-maximization (EM) algorithm can be applied with the
weights in the E step calculated via the forward-backward algorithm developed by Baum et al.
(1970). One typical issue for solving the likelihood using the EM algorithm is that the EM algorithm
may converge to a local maximum or a stationary point instead of the global maximum. Therefore,
it is important to use different starting values to solve the likelihood. An (2013) proposed a starting
value based on three consecutive observations to improve the convergence. As an alternative, Lange
and Minin (2013) developed a robust and efficient expectation-maximization algorithm based on a
complete data likelihood for parameter estimation.
3.2.2 Model Goodness-of-fit diagnostic tools
As described in the previous section, there are three key assumptions of the CTHMM: (i) conditional
on the current state, the future and the past are independent, i.e. the Markov property of the
underlying states; (ii) for a time-homogeneous Markov model, the transition intensities are constant
over time; (iii) the misclassification (emission) probabilities do not vary by time. It is also essential
to evaluate if this additional latent structure is necessary for the data compared to a basic Markov
model. Most of the diagnostic approaches in the literature for the misclassification CTHMM are
graphical. In general, the modified Pearson type goodness-of-fit test (Titman and Sharples, 2008)
could be used for either the basic Markov model or the CTHMM to evaluate the overall model fit.
Here we briefly review the diagnostic tools.
State-change plots compare the empirical Kaplan-Meier estimates of the transition between a spe-
cific pair of states to those predicted by the fitted model (Bureau et al., 2003; Titman and Sharples,
2010). Although the construction of the plots requires simulation to get the empirical estimates,
they provide informal but important information to visually assess the model’s overall goodness-
of-fit. Other methods of informal assessment include generalization of prevalence counts and con-
tingency tables for prediction of future observations (Titman and Sharples, 2008). The generalized
contingency table is more appropriate for unequally-spaced observations, in that the counts are
averaged over time periods instead of at a specific time point. Bureau et al. (2003) also recom-
mends comparing the estimated transition intensities from a fitted CTHMM to those from the basic
Markov model without the latent structure in order to determine whether or not the additional
latent structure provides a better fit to the data. Meanwhile, the estimated misclassification prob-
abilities can be compared to those in the existing literature and practical experience, if available.
A modified Pearson-type goodness-of-fit test by Titman and Sharples (2008) could be applied to
formally evaluate the model fit in the case of the misclassification CTHMM. The observations are
grouped by assessment number, time intervals, covariate categories, and quantiles of the estimated
transition intensities. The test can also accommodate the situation where there is an absorbing
state with a known exact entry time such as death in the data. Parametric bootstrapping is needed
for the test to estimate the asymptotic null distribution.
Finally, the invariance of misclassification probabilities over time can be examined to some extent
by both state change plots and the Pearson-type goodness-of-fit test in terms of overall model
goodness-of-fit. The likelihood ratio test between models with and without a time-varying covariate
of the misclassification probabilities can also be constructed for this purpose (Titman and Sharples,
2010).
3.3 Monte Carlo Simulation
3.3.1 Simulation setup
The simulation is set up as follows: for a given subject, a hidden continuous-time Markov process
which represents the true disease dynamics is simulated first with pre-specified transition intensity
matrix (Λ) assuming a homogeneous Markov chain and fixed, unequally-spaced observation sched-
ule. Conditioning on the true disease status, the observed states can then be generated with given
misclassification rate (MCR) πo|s. Varying parameters include size of transition intensities, the
magnitude of misclassification in the data, number of observations per subject, and total number of
subjects in the study. We consider three different sizes of transition (Λ): small, medium and large,
resulting in long, medium-long and short mean sojourn times. Six different misclassification rates
are simulated ranging from no misclassification to 40% misclassification. Without loss of generality,
we assume the misclassification probabilities are the same at both levels of the disease status in
the simulation, i.e.πo|s = P (O = 1|S = 0) = P (O = 0|S = 1). For each combination of Λ and πo|s,
5 and 10 unequally spaced observations per subject are generated with constraints that the same
first 5 observations are also included in the 10-observation scenarios. Thus an unequally-spaced
panel-observed timeframe is set up with comparable scenarios regarding the number of observa-
tions. The observation schedule is fixed at day 1, 3, 5, 8, and 12 for the 5-observation-time-points
scenario and additionally at day 13, 16, 20, 26, and 28 for the 10-observation-time-points scenario.
Compared to the three sizes of the transition, these observation schedules correspond to less than
1/3, around 0.5, and about the same length of the mean sojourn times. Moderate to large size
trials, with sample size equal to 500, are considered in the simulation for all combinations of the
above parameters. A smaller sample size equal to 100 is also examined in some scenarios. Detailed
parameter values are given in Table 6. The initial distribution is the distribution of the true states
at 1st time point: i.e.P (S(t1) = 1) = 0.4.
Table 6: Transition intensities and misclassification probabilities used in the simulation
Scenario Initial Dist’n λ01 λ10 πo|s Obs. Time Points
Small 0.4 0.04 0.1 0.05,0.2,0.25,0.3,0.4 5,10
Medium 0.4 0.2 0.15 0.05,0.2,0.25,0.3,0.4 5,10
Large 0.4 0.4 0.3 0.05,0.2,0.25,0.3,0.4 5,10
After data are generated, two types of models are fit to the simulated data with both true disease
and observed disease statuses: 1) the Basic Markov model (MM), estimating only the transition
intensities of the data, assuming no misclassification; 2) the CTHMM, estimating the transition
intensities and misclassification probabilities of the data simultaneously. For each scenario described
above, 500 trials are simulated using Monte Carlo simulation method. All simulations are carried
out using software R version 3.0.2 with package msm.
For all models, a Pearson-type goodness-of-fit test statistic is calculated, and corresponding p-values
are estimated. The significance level of the test is set at 0.05, meaning that a p-value less than 0.05
indicates poor fit of the model.
3.3.2 Simulation results
In all results presented below, the colors of the lines represent different transition intensities: blue
for small intensities ([0.04, 0.1]), black for medium intensities ([0.2, 0.15]) and red for large ([0.4,
0.3]) intensities. Each panel represents various misclassification probabilities from 0.05, 0.2, 0.25,
0.3 to 0.4. Within each panel, the number of observation varies as either 5 or 10. The dashed
horizontal lines represent the true parameter values in the simulation.
3.3.2.1 Estimated transition intensities Figures 11 and 12 show the results of the estimated
transition intensities λ̂01 and λ̂10, respectively. The error bars are the 95% empirical confidence
interval around the point estimates. Similar pattern can be seen for both λ̂01 and λ̂10. The accuracy
of the estimates is highly dependent on the size of the transition intensity and the misclassification
probabilities. The estimated transition intensities are almost unbiased for all sizes of transitions
with very tight 95% confidence interval when there is no misclassification error in the data. With
small (in blue)and medium (in black) true transition intensities, the estimated transition intensities
are nearly unbiased for almost all magnitude of MCR, except when the MCR is extremely large
(e.g. MCR = 40%). With large misclassification in the data, none of the models estimate the
transition intensities well, even with the small transition intensity case. The estimates are greatly
biased when the true transition intensity is large. However, the estimation is improved with more
observed time points except for the scenario with large transition intensity and large MCR.
3.3.2.2 Estimated misclassification probabilities Figures 13 and 14 show the results of the
estimated misclassification probabilities π̂o=1|s=0 and π̂o=0|s=1, respectively for all scenarios. In
panels labeled “No MC”, data modeled are correctly classified while still allowing the CTHMM
to estimate the misclassification probabilities. The dashed horizontal lines represent the true mis-
classification probabilities in the simulation. For scenarios with small (in blue) and medium (in
black) transition intensities, the estimated misclassification probabilities are almost unbiased even
for relatively large misclassification rate (MCR = 0.3). In the case of large transition intensities,
Figure 11: Estimated transition intensity λ̂01
the estimated misclassification rates are biased. No clear change pattern can be found for the
estimates with increasing MCR. However estimates are improved with more observed time points.
Since in reality, it is unknown whether data are misclassified, we fit CTHMM on the correct data,
allowing the model to estimate the misclassification probabilities as well. The estimated misclas-
sification probabilities in the case, where actually there is no misclassification, are ≤ 1% for the
small/medium transition intensities scenarios. For large intensities with 5 observed time points,
the estimated misclassification probabilities are around 5%, which may be misleading in practice.
However, these probabilities decrease if more observed time points are available.
3.3.2.3 Model diagnosis: Pearson type goodness-of-fit test A p-value based on the Pearson-
type goodness-of-fit test less than 0.05 indicates that the model is a poor fit. If the model assumption
is correct - that is, a basic Markov model fit the true data and a CTHMM fit the misclassified data
- a p-value of the test less than 0.05 should be observed 5% of the times among all simulation
Figure 12: Estimated transition intensity λ̂10
iterations. This represents the false likelihood of lack of fit (type I error) since the assumption
about the misclassification error is correctly specified or accounted for in the models. In contrast,
a higher percentage of p-value less than 0.05 should be expected if the model assumption is wrong.
In other words, a basic Markov model fitted on misclassified data and a CTHMM fitted on true
data should lead to a p-value less than 0.05 with greater frequency among all simulation iterations
depending how powerful the test is in the different scenarios.
Figure 15 shows the results of the Pearson-type goodness-of-fit test for 5 observed time points.
For CTHMM, the asymptotic null distribution of the test statistics is estimated via simulation
due to the latent structure (Titman and Sharples, 2008), and an upper and lower bound of the
p-values are obtained and presented for the test. When modeling data without misclassification,
5% of the tests indicate lack of fit with the basic Markov model, while almost none of the tests
advocate the CTHMM for the same data despite the relatively fewer data points (N = 500, 5
observed time points). However, when data are subject to misclassification, irrespective of the
Figure 13: Estimated misclassification probabilities for the observed data: π̂o=1|s=0
magnitude of misclassification in the data, the Pearson-type Goodness-of-fit test fails to identify
the correct model (i.e. the CTHMM) for the misclassified data most of the times. Although with
small transition intensities, chances of the tests having a p-value smaller than 0.05 for the wrong
models (MM) are greater than those with medium/large transition intensities, the tests ascertain
lack of fit for the correct model (CTHMM) too with high frequencies. A trend can be seen that
with more misclassification in the data, the tests are less likely to indicate lack of fit for the correct
models (CTHMM). However, with increasing misclassification, the same trend can also be found for
the wrong model (MM).With 10 observed time points (Figure 16), similar pattern can be seen as
in Figure 15 to diagnose the correct model (CTHMM) with improved performance. For the wrong
model (MM), with small transition intensities, almost all tests suggest poor model fit irrespective
of the misclassification rate except when the MCR is really high (MCR = 0.4). Increasing observed
time points does not improve the performance of the tests in the case with medium/large transition
intensities for the wrong model (MM).
Figure 14: Estimated misclassification probabilities for the observed data: π̂o=0|s=1
3.4 Modified likelihood and AIC
As seen in the previous section, the Pearson-type goodness-of-fit test does not do a good job
distinguishing between CTHMM and MM for data with misclassification. An alternative way
to compare the CTHMM and MM for misclassified data is to compare their likelihoods directly.
However, due to the structure of the model and the algorithm used to estimate the parameters,
the resulting likelihoods for both models are not comparable. For the CTHMM, the likelihood is
constructed for all observations as shown in section 2. For the MM, however, the observations at
the first time point are not included but are conditioned on while the likelihood is maximized. The
Figure 15: Pearson type goodness-of-fit test for 5 observed time points
likelihood of the MM can be expressed as:















where ni,j,l represents the total number of observed transitions from state i to state j at time tl.
The full likelihood, which includes the observations at the first time point, then can be modified
as:
f(s(t1), s(t2), . . . , s(tm)|Θ)





















Figure 16: Pearson type goodness-of-fit test for 10 observed time points
where π̂i(t1) is the estimated probability that the observed state at time t1 is i and ni,t1 is the
observed number of subjects belonging to state i at time ti. For a two-state MM, π̂i = p(s
(t1) =
i), i = 0, 1. Define the state distribution at t2 as ĉi, where ĉi = p(s
(t2) = i), i = 0, 1. Then, given
the state distribution π̂i at t1, the state distribution ĉ0 at t2 is:
ĉ0 = p00(t1, t2)× π̂0 + p10(t1, t2)× π̂1
where p00(t1, t2) is the probability of staying at state 0 from t1 to t2 and p10(t1, t2) is the probability
of transitioning from state 1 to state 0 from t1 to t2. Because π̂1 = 1− π̂0 and after a little algebra,




Therefore, the estimated distribution of the states at t1 can be calculated based on the estimated
transition probability p̂ij from t1 to t2 and the estimated state distribution ĉi at t2. For more than
two states, the estimated distribution of the states at t1 can be calculated in a similar way (See
appendix for the results of three states).
Then AIC for both CTHMM and MM can be calculated and compared using:
AIC = 2k − 2ln(Lfull)
where k is the number of the parameters estimated in the models and Lfull is the likelihood of the
full data. A smaller AIC indicates better model fit.
To investigate the performance of the AIC, we conducted Monte Carlo simulations. The simulation
is set up in the same way as in the previous section. A total of 500 data sets are simulated for
each scenario. The performance of the AIC is described as the percentage of times that the AIC
identifies the correct model. That is, for data without misclassification, MM fit the data better
and should have a smaller AIC compared to fitting CTHMM on the same data; for data with
misclassification, CTHMM should have a smaller AIC instead.
Figure 17 presents the results of AIC for all scenarios. When there is no misclassification (No MC),
based on the AIC, CTHMM are selected as the correct model for the data 5% among the simulation
iterations with all three different sizes of transition intensities. This represents the probability that
a wrong decision is made based on the AIC, where the MM should be chosen for data without
misclassification. For data with misclassification, in the case with small transition intensity (in
blue), the CTHMM are correctly selected by AIC most of the time, except when the MCR is high
(e.g. MCR = 40%). With medium-size transition intensity (in black), the performance of the AIC
declines, especially with small (e.g. 5%) and relatively large (e.g. 30%) MCR. The performance of
the AIC is even worse in the scenarios with large transition intensity (in red). In less than 20% of
the simulation iterations, the AIC advocates the CTHMM as the correct model for the misclassified
data. However, the performance of the AIC is improved in all scenarios with increasing number
of the observations from 5 to 10, even with very large MCR. The improvement is dramatic for
scenarios with medium transition intensity (in black). That is, with more observations per subject,
more information can be gathered to compare the models.
Figure 17: Performance of AIC based on the modified likelihood of MM
3.5 Discussion
The CTHMM has been proposed to model panel-observed data subject to misclassification. While
the two-layer structures provide a flexible framework to model the data, the estimability and/or
accuracy of all parameters and model diagnosis are challenging due to the uncertainty of the hidden
layer and the inherent drawbacks of the EM algorithm. Although studies have been done to improve
the estimation and the assessment of the model fit, limited work has shown the performance of
CTHMM with application to misclassified data. We evaluate the performance of such models with a
focus on the estimation of the misclassification probabilities solved by the most common algorithm
implemented in the literature. We also propose an alternative approach for model diagnosis using
AIC based on the modified full-data likelihood.
In our simulation, all parameters are estimable; however, the accuracy of the estimation varies.
One key parameter that impacts the estimation is the transition intensity. For small to medium
transition intensities corresponding to long to mid-length mean sojourn time relative to the ob-
servation intervals, parameters including transition and misclassification can be well estimated as
long as the classification error is not too high (MCR < 30%). A similar result was discussed by
Rosychuk et al. (2004). In their simulation, all the interval times are equal to 7 days with mild
misclassification (2% and 10%). They found that in order to estimate the parameters accurately,
the mean sojourn time needs to be at least three times the observation interval time. In other
words, we need to collect the data often enough to get enough information about the parameter. In
our simulation, because our observation schedule is unequally spaced, this may introduce additional
variability - more information - to the model. Thus in the case with medium transition intensities,
where the mean sojourn time is about twice as long as the simulated interval time, parameters can
still be well estimated. For the large intensities case, although the estimated transition intensities
are quite biased, the estimated misclassification probabilities are reasonably close to the true pa-
rameter values. In such case, we can still glean some insight into the potential misclassification
error even though the transition intensities are poorly estimated. For higher misclassification rates
(> 30%), the point estimates of the misclassification probabilities are biased, even with small tran-
sition intensities. Changing the initial values of the parameters does not improve the accuracy of
the estimation. We explored this issue (results not shown) for the two-state cases and find that
with a large amount misclassification, the surface of the likelihood is flattened, which makes it
difficult for the algorithm to converge to the true parameter value, no matter which starting value
is given, a problem discussed by Rosychuk et al. (Rosychuk and Thompson, 2003; Rosychuk RJ,
2004). Furthermore, with more observations per subject (e.g. 10 observations per subject), the
point estimates are improved and the uncertainty of the estimates is reduced.
We also found that the modified Pearson-type goodness-of-fit test does not work well to identify
a correct model for the misclassified data in our simulation. The poor performance may be partly
due to lack of power. As we have seen in the simulation, with more observations, the performance
of the Pearson-type goodness-of-fit test is improved. On the other hand, due to the latent structure
of the CTHMM, the estimated counts of individual cell are calculated by summing over all possible
latent states, which may potentially impose more difficulties on identifying the fit of the models. Our
proposed AIC approach works well in terms of selecting the right model for the data with or without
misclassification. However, the performance of our proposed approach is also greatly impacted by
the relative size of the transition intensities compared to the observation schedule, although it can
be improved with more observed time points. In addition, violation of other assumptions may also
influence the performance of the test; applying different procedures including graphical approaches
are recommended to assess the model fit thoroughly.
We also explored the impact of small sample size (n = 100) on the performance of the model (results
are not shown). In cases with small transition intensities, the performance of the CTHMM with
respect to point estimates and our proposed AIC approach are similar to that when the sample
size is medium to large (n = 500). In scenarios with medium and large transition intensity, the
estimated misclassification probabilities are still close to the true values although biased. However,
our proposed AIC approach suffers when the size of the transition intensity is medium when n
= 100. Among all simulation iterations, less than 30% of the times the models are identified
correctly with only 5 observations per subject. Increasing the total number of observations per
subject improves the performance from 30% to around 65%. With large transition intensity, the
performance is worse than the small/median transition intensity cases. That is to say, in order to
identify the misclassification error, either a large enough sample size or a frequent sampling scheme
(i.e. follow-up schedule) is needed to draw the conclusion.
There are some limitations of this study. First, we assume the state space is known beforehand.
However, the state space may not be known, especially if we use categorized scores to represent
the state space. Various ways are described to categorize a single score, which may potentially
impose issues on the resulting estimates. Secondly, the assumption of constant misclassification
probabilities may also be questionable in practice. In a longitudinal study setting, physicians may
make fewer errors after they see the patients more often and repeatedly. Therefore it may be
more realistic to assume that the misclassification probabilities decrease as time goes on. This
assumption needs to be assessed and will be a future topic for study.
In summary, CTHMM can be applied to estimate misclassification probabilities while taking into
account changes of disease statuses. Although the assumptions of such models are strong, the results
still provide useful information about potential error, especially if misclassification probabilities are
not too high. If the Markov assumption is reasonable for given data with repeated measurements,
one could start with CTHMM since, as we have shown in the simulation, with correctly classified
data, estimates from CTHMM are small and AIC based on the modified likelihood can identify the
correct model. The estimated misclassification probabilities then can be used for the purpose of
bias correction. In addition, if the estimated transition intensities are small, i.e. the mean sojourn
time is long relative to the interval time of the observation schedule, one can be confident about
the results. Otherwise, data need to be collected more often in order to get better estimates or the
accuracy of the estimates might be questionable.
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ĉ0 = p̂00π̂0 + p̂10π̂1 + p̂20π̂2
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Abstract
Covariate-adjusted regression analysis is very common to analyze data from randomized
clinical trials to demonstrate the effect of an intervention. However, adjusting for misclassi-
fied covariate will result in biased estimate for the treatment effect, which is assumed to be
measured without error. We propose a joint modeling analysis strategy, which combine the
continuous-time hidden Markov model (CTHMM) and the misclassification simulation extrapo-
lation (MCSIMEX) method to correct the bias of the estimate for the treatment effect when the
misclassified covariate is measured repeatedly. We demonstrate the performance of the CTM-
MCSIMEX estimator in terms of type I error, power for the hypothesis testing of the treatment
effect and bias correction of the estimates. With mild to moderate misclassification in the co-
variate, more than 50% of the bias can be corrected by CTM-MCSIMEX estimator given that
the misclassification probabilities can be estimated by CTHMM accurately in the first stage.
However, the power of the hypothesis testing is not improved and the type I error is slightly
inflated using CTM-MCSIMEX estimator. Estimates based on CTM-MCSIMEX estimator can
provide some insight of the treatment effect when no misclassification error can be assumed and
can be used as reference for future study design.
Key words: CTHMM, MCSIMEX, covariate misclassification, bias correction
4.1 Introduction
Covariate-adjusted regression analysis is very common to analyze data from randomized clinical
trials to demonstrate the effect of an intervention. Incorrect measurement of the required covariates
could potentially cause problems for the pursuit of effective prognostic adjustment, resulting in both
biased treatment effect estimation and power loss for hypothesis testing. When the mis-measured
variable is categorical, it is referred to as misclassification. Measurement error has been a long-
standing topic in the statistical literature, primarily in the context of observational studies, where
the misclassified variable is of main interest. Methods have been proposed to correct the bias
associated with the estimate of the misclassified variable. However, in the clinical trials setting,
emphasis is more likely to be on the estimation of the effect associated with the treatment, which
is considered to be recorded without error. Although these proposed methods developed for a
misclassified variable may be applied for a perfectly measured variable as well, limited research has
focused on the performance of bias correction with respect to the perfectly measured variable using
such methods.
It is not uncommon for prognostic covariates to be measured with error or misclassified. For
example, disease severity is an important prognostic covariate for most diseases and is often adjusted
for in an analytic model for the primary analysis. However, the evaluation of the severity may
be easily confounded by inter-observer variability or clinical conditions such as sedation and/or
intubation or drug or alcohol usage, resulting in inaccurate assessment. The National Institutes of
Health Stroke Scale (NIHSS) for stroke and the Glasgow Coma Scale (GCS) for traumatic brain
injury (TBI) are two examples. In addition, the adjustment of the disease severity is often based
on categorized scales for both biological and statistical consideration. No direct assessment is
available to validate the accuracy of such evaluations and categorizations. Therefore, the true
severity is unknown in most cases.
Many approaches developed for correcting covariate misclassification are two-stage models. In the
first stage, the parameters describing the characteristics of misclassification are estimated using
an internal/external validation data set, repeated measurements, or instrument variables. Those
parameters can then be incorporated in the analytic model as weights in the second stage. Since
the true severity is unknown in the examples given earlier, we will focus on the methods using
repeated measurements. White et al. (2001) demonstrate the possibility of using regression cali-
bration for error-prone categorical variables when more than two measurements of the variable are
available. Wang et al. (2000) propose an Expected Estimating Equation (EEE) method to account
for the measurement error in longitudinal data. With misclassification, method of moments is
recommended to solve for the EEE. Chen et al. (2014) propose a two-stage estimation approach
for longitudinal ordinal data with misclassification in both the response and covariates based on
estimating equations.
Multistate models (MSM) are very useful tools to model disease dynamics and have been widely
used for longitudinal categorical data (Diggle et al., 2002). The continuous-time hidden Markov
Models (CTHMM) are one type of MSM, which provide a convenient framework to simultaneously
estimate disease development and potential probability of misclassification of the data (Bureau
et al., 2003). The disease dynamics are captured in the transition through latent states, which
follows a continuous-time Markov chain; the misclassification is characterized via the emission
probabilities, which are the probabilities of the observed status given the underlying true disease
status. Jackson et al. (2003) proposed such application of CTHMM for data subject to misclassifi-
cation and developed an R package (msm) to ease model fitting. CTHMMs have also been applied
to data in different disease areas including cognitive decline and dementia (Marioni et al., 2012;
Norton et al., 2013; Buter et al., 2008), HIV/HPV (Human Papilloma Virus) infection (Blitz et al.,
2013), liver cirrhosis and hepatitis C (Bartolomeo et al., 2011; Terrault et al., 2008; Sweeting et al.,
2006).
The Misclassification Simulation Extrapolation model (MCSIMEX) is an extension of the Simu-
lation Extrapolation model (SIMEX), which was originally designed for continuous measurement
error (Kuchenhoff et al., 2006). The basic idea of MCSIMEX is that, given the known misclassifi-
cation probabilities in the data, the behavior of the estimation from the model can be “calibrated”
by adding extra known increments of misclassification into the data. Therefore, the inference in the
case where there is no misclassification can be obtained by extrapolating the trend/behavior back.
It can be applied to covariate misclassification, outcome misclassification or both. Due to its ease of
implementation and flexibility of dealing with more complicated modeling, MCSIMEX has received
considerable attention with application to genotyping data (Lamina et al., 2010; Heid et al., 2008),
periodontal disease (Slate and Bandyopadhyay, 2009), social science (Hopkins and King, 2010) and
occupational disease (Costas et al., 2015). However, there has not been an extensive assessment of
the performance of MCSIMEX in the literature.
In this paper we demonstrate the feasibility and performance of combining the two models, the
CTHMM and the MCSIMEX in the context of estimating an exactly measured variable when a
potentially confounding variable is mis-measured. The joint modeling provides a flexible way to
adjust for the biased estimate of the treatment effect caused by covariate misclassification in the
situation where the misclassification probabilities are unknown, but repeated measurements for the
misclassified variables are available. We first assess the performance of MCSIMEX regarding bias
correction for the perfectly measured variable. Then the two models are combined to provide the
estimation of the treatment effect given the prognostic covariate with correction for misclassification.
All evaluations are carried out using Monte Carlo Simulation methods. The paper is organized as
follows. We introduce a motivating example in section 2. The analysis strategy is described in
section 3. In section 4, the simulation used to evaluate the performance of the MCSIMEX model
and the combined approach is described, and the results are presented. The combined approach is
then applied to analyze the motivating data, and the results are presented in section 5. We close
the paper with discussion and recommendations based on the simulation results.
4.2 Motivating example: The IMS III trial
The Interventional Management of Stroke (IMS) III trial (Broderick, 2013) was a randomized
controlled phase III trial, designed to determine the efficacy of endovascular therapy following
intravenous rt-PA initiated within 3 hours of symptom onset of ischemic stroke. The primary
outcome was functional recovery at 3 months post-stroke, defined based on the modified Rankin
Scale (mRS), which was dichotomized as favorable outcome (mRS 0-2) vs. unfavorable outcome
(mRS > 2). Adjustment for baseline stroke severity was prespecified.
The stroke severity was defined based on dichotomized NIHSS (the National Institutes of Health
Stroke Scale) with NIHSS ≤ 20 representing a moderate stroke and NIHSS ≥ 21 a severe stroke.
Some misclassification of the stroke severity was discovered during the data monitoring process.
Approximately 2% misclassification was identified at each level of the stroke severity by the review
of the Data and Safety Monitoring Board during the trial. Moreover, some residual error may
still exist either due to the uncertainty of the selected cutoff point for dichotomization or other
confounding factors while evaluating patients’ stroke severity. Therefore, the true misclassification
rate of stroke severity was unknown and no validation data were available. In addition to baseline
NIHSS, all subjects were evaluated repeatedly using NIHSS at 40 minutes, 24 hours, and 5 days,
which provided extra information to estimate the true magnitude of misclassification.
For ease of illustration, we assume stroke severity, which is referred to as the misclassified covariate,
is the only covariate that needs to be adjusted for in the primary analysis. We will refer to the
treatment assignment as a perfectly measured variable in the model, which is a common assumption
in practice for intention to treat analysis.
4.3 General consideration for analysis strategy
We will focus on the logistic regression model with additional information of repeated measure-
ments for the error-prone covariate since this is the scenarios described in our motivating example.
In order to correctly estimate the treatment effect accounting for the covariate misclassification, we
propose a two-stage modelling strategy, which combines the CTHMM and the MCSIMEX model.
In the first stage, the error-prone covariate will be treated as the outcome, and the misclassification
probabilities will be estimated via CTHMM. Then in the second stage, the estimated misclassi-
fication probabilities from the CTHMM will be incorporated into the MCSIMEX algorithm, and
the inference about the treatment effect will be made according to the pre-specified analytic model
after MCSIMEX correction. Detailed setup for the two-stage modelling is described below. For
ease of notation, we will omit the subscript i, representing the ith subject in the study throughout.
4.3.1 Misclassification Model
Suppose the true stroke severity at time point tm, denoted as S
(tm),m = 1, 2, . . . , n, follows a
continuous time Markov chain with state space S = {0, 1}, where 0 and 1 represent a mild and
a severe stroke respectively. Then the transition of the true severity between time points tm and
tm+1 is captured via transition intensity, denoted as λlj , with l, j representing states occupied,l, j =
{0, 1}, and λlj = lim∆t→0
Pr(S(tm+1)=j|S(tm)=l)
∆t . The transition probabilities between time points
can be calculated via matrix exponential for a given time interval ∆t between time points. For the
two-state case, direct calculation can be carried out using an analytic expression as:
P01(∆tm) = P (S
(tm+1) = 1|S(tm) = 0) = λ01
λ01+λ10
{1− e−∆tm(λ01+λ10)}
P10(∆tm) = P (S
(tm+1) = 0|S(tm) = 1) = λ10
λ01+λ10
{1− e−∆tm(λ01+λ10)}
Conditioning on the true severity, the observed severity,O(tm), O = {0, 1},m = 1, 2, . . . , n, defined
according to NIHSS is independent across the time points and has the misclassification probabilities
defined as πo|s = Pr(O
(tm) = l|S(tm) = j). We assume the misclassification probabilities remain
constant across all time points. Together with the distribution of the true severity at m = 1, the
observed data likelihood can be expressed as:





















The likelihood can be solved and the misclassification probabilities can be estimated via the Expec-
tation Maximization (EM) - forward and backward algorithm developed by Baum et al. (Baum,
1970).
4.3.2 The Analytic model
Let Y denote the dichotomized primary outcome of interest. The primary analytic model has the
form:
Logit{Pr(Y = 1|Z, S(t1))} = β0 + βzZ + βsS
(t1)
where Z represents the treatment assignment and is recorded without error. S(t1) is the error-prone
dichotomized prognostic covariate at baseline (tm = t1). In the case of misclassification, S
(t1) is
not observed, but O(t1), the misclassified version of S(t1), is observed. Then the above equation
becomes:






We refer to the β∗s as naive estimators. With the estimated misclassification probabilities (Π)
and a parametric approximation, β∗(Πζ) ≈ F (1 + ζ,Γ), where ζ is the amount of misclassifica-
tion in addition to that already in the data and Γ is the extrapolation function, the MCSIMEX
estimators or the corrected estimators can be extrapolated back to when ζ = −1, representing no
misclassification. Detailed information about the algorithm can be found in (Kuchenhoff et al.,
2006).
4.4 Monte Carlo Simulation
Simulation is used to investigate the feasibility and performance of combining the two methods,
the CTHMM and the MCSIMEX, in order to correctly estimate the treatment effect, accounting
for covariate misclassification. As illustrated in our previous work, CTHMM can well estimate the
misclassification probabilities for data subject to misclassification. For this paper, we first show the
performance of the MCSIMEX model regarding bias correction for the perfectly measured variable
with respect to the accuracy of the estimated misclassification probabilities and the relative covari-
ate effect to the treatment. Secondly, we examine the bias correction for the perfectly measured
variable using the joint model.
4.4.1Performance of MCSIMEX model
Both treatment assignment Z and true stroke severity at baseline S(t1) are generated form a
Bernoulli distribution with pz = 0.5 for Z and ps(t1) = 0.4 for S
(t1) respectively. That is,
Pr(Z = 1) = Pr(Z = 0) = 0.5 and Pr(S(t1) = 1) = 0.4. A misclassified version of S(t1), de-
noted as O(t1), is also generated with various misclassification rate(MCR) from 0 to 40%, assuming
that the misclassification rates (MCRs) are the same for each level of the prognostic covariate(i.e.
π01 = Pr(O = 0|S = 1) = π10 = Pr(O = 1|S = 0)). The response variable Y is generated from
a Bernoulli distribution where the Pr(Y = 1) is calculated based on the linear combination of Z,
S(t1) and their corresponding coefficients, which vary across levels of βs from -0.5 to -2.5 while
fixing βz at 0.405. this resulted in a wide randg of absolute relative effect sizes of the covariate to
that of the treatment (i.e. βs/βz) from around 1.2 to 6.2. After the data are generated, a total of
5 models are fit on either the true data (i.e. Y, Z, S(t1)) or the misclassified data (i.e. Y, Z,O(t1))
with or without MCSIMEX correction, listed as follows:
i) True model: adjusted for the true covariate value Z;
ii) Näıve model: adjusted for the misclassified covariate value O(t1) ;
iii) True MCSIMEX model (MCSIMEX.true): apply the MCSIMEX correction using the true
misclassification probability with which data were generated;
iv) Mis-specified MCSIMEX model1 (MCSIMEX.mis1): apply the MCSIMEX correction with
mis-specified MCR at 30% less than the truth for all scenarios;
v) Mis-specified MCSIMEX model2 (MCSIMEX.mis2): apply the MCSIMEX correction with mis-
specified MCR at 30% more than the truth for all scenarios.
For the MCSIMEX models, we used the quadratic extrapolation function to calculate the MC-
SIMEX estimators because it has better performance than the linear extrapolation function (Kuchen-
hoff et al., 2006). For each scenario described above, 1,000 datasets were simulated using Monte
Carlo simulation method. The empirical percent bias and mean squared error of the estimated β̂z









where βtrue is the true coefficient value.
Figure 18 presents the results for the impact of MCR for a given treatment effect (βz = 0.405)
on the estimated β̂ coefficient of the treatment (upper panel) and of the covariate (lower panel).
With the correctly specified MCSIMEX.true model, the absolute percent bias (left panel) increases
as the MCR increases for both estimates (dashed black lines). However when the misclassification
probabilities are mis-specified, the MCSIMEX model tends to correct less bias with smaller MCR
(MCSIMEX.mis1: green lines) and overcorrect the bias (MCSIMEX.mis2: red lines) compared to
the cases when the true MCR is used for the correction. Especially for relatively small MCR,
estimates based on MCSIMEX.mis2 are greater than those based on the true models. The mean
squared error of all the MCSIMEX estimators for the treatment effect (top right plot) is reasonably
small, which indicates that the estimators are relatively close to the true parameter values.
Figure 19 presents the results for the impact of the covariate effect on the bias correction for a given
misclassification rate (MCR = 0.2). Similar patterns are observed for both percent bias and MSE for
the estimated coefficient of the treatment effect compared to the impact of varying misclassification
rates. With smaller covariate effect on the outcome, percent bias of the treatment effect reduces with
Figure 18: Impact of MCR on the performance of MCSIMEX
MCSIMEX correction. On the other hand, the covariate effect does not influence the magnitude
of bias correction for the misclassified covariate itself. That is, the amount of correction for the
misclassified covariate in terms of percent bias stays almost the same with increasing covariate
effect.
4.4.2 Performance of the Joint Model
For this simulation, we evaluate the performance of combining the two models in terms of the
bias correction, power and type I error with respect to the treatment effect. Suppose an adjusted
model is pre-specified as the primary analysis for a randomized controlled clinical trial, designed
Figure 19: Impact of magnitude of covariate effect on the performance of MCSIMEX
to detect an absolute 10% difference in the treatments, with the success rate in the control group
equal to 40%. This is the same assumption made in the IMS III trial (Broderick, 2013). A sample
size of 1000 (500 subjects per group) is estimated to detect this unadjusted odds ratio of 1.5 for
the treatment effect with 90% power at a 5% significance level. The prognostic covariate that the
model is adjusted for is dichotomized and known to be subject to classification error, although the
misclassification rates are unknown. However, additional measurements other than the baseline
for the covariate are available at the time of the analysis. Five hundred trials are simulated using
Monte Carlo simulation methods for each scenario described below. The empirical percent bias
and mean squared error for the estimates of the treatment effect is calculated as in the previous
section.
In each trial, repeated measurements of the covariate were simulated first with 5 unequally-spaced
observations per subject, i.e. the true stroke severity that a subject belongs to at each time point
tm. The true severity S
(tm) = i, i = {0, 1}, tm = {1, 3, 5, 8, 12} are assumed to follow a homogeneous











where the rows represent the current severity at time tm and the columns are the severity at time
tm+1. That is, the rate of transition from state 0 to state 1 is 0.4 and from state 1 to state 0 is
0.3. Given the true severity, misclassified versions of the covariate at each time point are generated
as described in the previous section, with varying misclassification magnitudes ranging from 0% to
40% . The outcome Y is also generated as described in section 3. A total of 3 final analytic models
are compared:
i) True model: adjusted for the true covariate value;
ii) Näıve model: adjusted for the misclassified covariate value;
iii) CTM-MCSIMEX model: The joint model, which estimates the misclassification probabilities
via CTHMM first and then applies the MCSIMEX algorithm with the estimated misclassifi-
cation probabilities to the Näıve model.
Since in reality, it is unknown whether misclassification truly exists in the observed data, mis-
classification probabilities will also be estimated in the simulated true data and the corresponding
MCSIMEX estimator is also obtained for the true data.
Table 7 presents the results of the impact of the magnitude of the covariate misclassification on
the estimation for the treatment effect. With increasing misclassification rates of the covariate,
percent bias of the point estimate in the näıve models increases greatly, from 6.27% in the mild
misclassification case to about 25% in the severe misclassification. The misclassification probabil-
ities are estimated reasonably well via CTHMM; the MCSIMEX estimators partially reduce the
bias. CTM-MCSIMEX works for mild and moderate misclassification, where ≥ 50% bias reduction
is achieved. However, when a large amount of misclassification (>30%) exists in the covariate,
CTM-MCSIMEX estimators do not perform well. In addition, using MCSIMEX estimators do not
improve the power of the hypothesis testing for the treatment effect. The power when using the
MCSIMEX estimators is similar to that when using the Näıve models. In addition, type I error
rates are also slightly inflated using CTM-MCSIMEX estimators compared to the true model and
the näıve model.
Table 7: %Bias, MSE, Power and Type I Error for the estimated treatment effect
Estimators(β̂trt) True parameters: βtrt=0.405, βsev=-2.4
MCR*(Est.MCR) Models Mean(% Bias) SE MSE Power Type I Error
(0,0)
(0.015,0.014)
True 0.4012(-0.94%) 0.1488 0.0222 0.798 0.051
Naive - - - - -
CTM-MCSIMEX 0.4107(1.4%) 0.1517 0.0230 0.782 0.054
(0.05,0.05)
(0.055,0.054)
True 0.4064(-0.10%) 0.1395 0.0195 0.794 0.049
Naive 0.3796(-6.27%) 0.1350 0.0189 0.756 0.052
CTM-MCSIMEX 0.4038(-0.30%) 0.1499 0.0225 0.754 0.056
(0.2,0.2)
(0.190,0.190)
True 0.4011(-0.96%) 0.1489 0.0222 0.762 0.053
Naive 0.3260(-19.51%) 0.1344 0.0243 0.658 0.050
CTM-MCSIMEX 0.3597(-11.19%) 0.1559 0.0264 0.664 0.057
(0.3,0.3)
(0.270,0.267)
True 0.4174(-3.05%) 0.1465 0.0216 0.790 0.051
Naive 0.3162(-21.92%) 0.1246 0.0234 0.686 0.048
CTM-MCSIMEX 0.3322(-17.96%) 0.1354 0.0236 0.676 0.058
(0.4,0.4)
(0.383,0.381)
True 0.4140(2.22%) 0.1521 0.0232 0.782 0.054
Naive 0.3014(-25.58%) 0.1298 0.0276 0.632 0.050
CTM-MCSIMEX 0.3073(-24.12%) 0.1346 0.0277 0.652 0.056
*Assuming misclassificaiton probabilities are the same at both levels of the severity; Est.MCR: estimated
misclassification probabilities from CTHMM, (π̂1|0, π̂0|1):
π̂0|1 = Pr(O
(t1) = 0|S(t1) = 1), π̂1|0 = Pr(O
(t1) = 1|S(t1) = 0)
4.5 Application
We applied the joint modeling strategy to real data from the IMS III trial. A total of 521 subjects
were included in the analysis, all of which had 4 repeated measurements of NIHSS at baseline, and
40 minutes, 24 hours and 5 days after symptom onset. The misclassification probabilities of the
Table 8: Estimated coefficients in the naive model and CTM-MCSIMEX model
Coefficients
Naive Model CTM-MCSIMEX
Estimates SE Estimates SE
Intercept -0.0977 0.150 -0.0575 0.153
Treatment 0.0668 0.175 0.0633 0.178
Severity -1.2660 0.196 -1.476 0.220
dichotomized NIHSS (stroke severity) were first estimated via CTHMM with the unit of the time
in days, i.e. t = {0, 0.03, 1, 5}. According to our previous work, a CTHMM with piecewise constant
transition intensity fit the data better; therefore the resulting misclassification probabilities from
such CTHMM were used for the bias correction using MCSIMEX model in the second stage. In
the primary analysis, the treatment effect was assessed via Cochran-Mantel-Haenszel test, with
adjustment for the baseline stroke severity defined according to NIHSS. To be consistent with the
primary analysis specified in the Statistical Analysis Plan, only dichotomized NIHSS was adjusted
for in the analytic model, in addition to the treatment assignment.
Based on CTHMM, about 3.8% (95%CI: [0.0302, 0.0423]) of the subjects with mild/moderate
stroke were misclassified as a severe stroke. The misclassification probability for subjects with
severe stroke was almost double that of those with mild/moderate (6.6%, 95%CI: [0.0554, 0.0782]).
Table 8 presents the results for the naive model as well as CTM-MCSIMEX estimators. The
primary analysis from the IMS III trial was not able to demonstrate the treatment efficacy; using
the CTM-MCSIMEX estimator, we confirmed the finding with a smaller estimated coefficient for
the treatment and slightly larger standard error of the estimate.
4.6 Discussion
In this paper, we demonstrated the feasibility and the performance of combining CTHMM and
MCSIMEX algorithm to correct the estimation bias for the perfectly measured variable (e.g. treat-
ment assignment) caused by covariate misclassification when no gold standard for the misclassified
variable is available. The repeated measurements of the misclassified variable provide additional
information for the error process. For data with mild to moderate misclassification (e.g. < 20%),
bias correction for the perfect measured variable using this joint modeling strategy is reasonable
provided that the estimated misclassification probabilities in the first stage are relatively accurate.
However, the bias correction is attenuated significantly when misclassification probabilities in the
covariate are greater than 30%. Large amount of bias remains uncorrected even with the CTM-
MCSIMEX estimators. In such case, as far as our knowledge, no methods in the literature can
provide a good bias correction. On the other hand, if the estimated misclassification probabilities
are small, e.g. total error rate (π1|0 + π0|1) < 5%, joint modeling is not necessary. With such
small amounts of misclassification of the covariate, the impact on the perfectly measured variable
is small. In addition, if data are not misclassified, using CTHMM can still provide estimation of
misclassification probabilities, although with small magnitude, which results in overcorrection of
the parameter estimation for the perfect measured variable via MCSIMEX model as demonstrated
in our simulation.
While the point estimates are improved using joint modeling, the power of the hypothesis testing
for the treatment effect is also impacted and is similar to the näıve model without correction.
This may partly be due to the simulation procedure in the MCSIMEX algorithm introducing extra
variability into the simulated data, resulting in large standard errors while making inference. In
addition, the combined approach also leads to a slightly inflated type I error probability. Since the
misclassification probabilities used in the MCSIMEX algorithm are estimated from the first stage,
the variances of the estimated misclassification probabilities are not fully considered in the second
stage even with the increased standard error estimation in the MCSIMEX algorithm. Thus, further
research is needed to improve the variance estimation for the parameter estimates, which could
incorporate the variability of the estimation for the misclassification probabilities using repeated
measurements.
In the simulations, we only demonstrate simple cases where no additional covariates were adjusted
for in either CTHMM or MCSIMEX model. However, the joint modeling strategy is flexible. If
there is external information about misclassification probabilities, it could be incorporated into
the CTHMM directly. Likelihood ratio tests could be applied to compare if such adjustment is
needed. Other information, such as death, could also be included in the CTHMM while estimating
the misclassification probabilities (Jackson et al., 2003; Jackson and Sharples, 2002), which may
potentially improve the estimation for the misclassification probabilities given the certainty of the
death information.
There are some limitations in this study. The assumption that the misclassification probabilities are
the same across all time points is strong. It may be the case that the misclassification probabilities
decrease over time; that is, the evaluation of the disease severity for individual subjects is improved
over time. Therefore, a time varying misclassification matrix may be more appropriate in this
case. This will be addressed in future works. Secondly, we only evaluate the performance for the
two-state cases; further exploration is needed for the scenario with more states.
In summary, the joint analysis strategy can be applied to adjust the estimation bias of the per-
fectly measured variable caused by covariate misclassification when repeated measurements of the
covariate are available. With mild to moderate misclassification in the covariate, the performance
of CTM-MCSIMEX estimator in terms of bias correction is reasonable. With the flexibility of the
joint modelling strategy and ease of implementation, it can be applied to more complicate modelling
such as survival analysis.
5 Summary and Conclusions
5.1 Conclusions
This work mainly focuses on a common practical issue of covariate misclassification under covariate-
adaptive randomization. However, the emphasis surrounds the impact on both the type I error and
power of the hypothesis testing and bias of the estimate for the perfectly measured variable (e.g.
treatment effect). To understand such impact, we first demonstrate theoretically and through sim-
ulation that under covariate-adaptive randomization, type I error can be maintained if the same
misclassified covariate is adjusted for both during randomization procedures and in the analysis.
However, adjusting for the misclassified covariate in the analysis will lead to power loss and biased
estimation for the perfectly measured variable using generalized linear regression. The magnitude
of power loss and bias is not ignorable, especially when the covariate effect on the outcome is large
relative to the treatment effect, or the misclassification rate is relatively high (Original paper I).
Secondly, in order to identify the misclassification error in the covariate, we illustrate the perfor-
mance of the CTHMM with a focus on estimating misclassification probabilities when a repeatedly
measured error-prone covariate is available. We propose to use AIC, which is calculated based on a
modified likelihood of estimated parameters given data, to directly compare between models with
and without misclassification. We show through simulation that the AIC approach behaves much
better, in terms of identifying the correct model for the misclassified data, than the Pearson-type
goodness-of-fit test in terms of identifying the correct model for the misclassified data, which is
the only formal test currently in the literature (Original manuscript II). Further, we propose a
two-stage analysis strategy, which combines the CTHMM and MCSIMEX models to correct the
estimation bias for the treatment effect. It provides at least 50% bias correction when there is mild
to moderate misclassification in the covariate (e.g. < 20%). The performance is comparable to
other methods in the literature. In addition, the two-stage modeling strategy is flexible in terms
of dealing with complicated analysis model and easy to implement. Estimates based on CTM-
MCSIMEX may provide some insight into the treatment effect when no misclassification error can
be assumed and be used for future study design (Original manuscript III).
5.2 Strengths & Limitations
This work mainly focuses on the estimation of the perfectly measured variable when there is co-
variate misclassification. It simultaneously takes into consideration the disease development as well
as the uncertainty of diagnosis for disease severity. It maximizes the utility of the available infor-
mation which makes more biological sense, and also accounts for real practice, both clinically and
statistically. To the best of our knowledge, no study has emphasized the importance of and meth-
ods related to estimation of the perfectly measured variable under misclassification of prognostic
covariates.
There are several limitations of this study. First of all, we are not able to deal with covariates
that are not ordinal, like race or cancer type, since those variables do not transit between types
(states). For simplicity, we only consider two-state scenarios with no additional covariate adjust-
ment in either the CTHMM or the MCSIMEX model in the simulation. In addition, we assume
the misclassification probabilities are the same across all time points. This may not be true in
real practices; the misclassification probabilities may reduce after the disease has stabilized, and
physicians may become more familiar with patient status over time.
5.3 Future Directions
Although we have demonstrated the performance of the CTHMM with a focus on estimating mis-
classification probabilities and the feasibility of combining the CTHMM and the MCSIMEX models
for correcting the bias for the perfectly measured variable, there is still much work to do. First
of all, it is reasonable to assume that the misclassification probabilities vary over time. Therefore,
a time varying misclassification matrix should be considered in the analysis. This can be done
either by adding a random effect or imposing known correlation structures to the misclassification
probabilities. The performance of such a model needs to be evaluated, including parameter iden-
tification, point estimation and model diagnosis. In addition, more complicated scenarios such as
three or more states, additional covariates on the misclassification probabilities or the outcome,
death should be considered and incorporated into analyses. Because those scenarios may provide
additional information for parameter estimation, therefore are worth further studying in depth.
6 References
Jr. Adams, H. P., P. H. Davis, E. C. Leira, K. C. Chang, B. H. Bendixen, W. R. Clarke, R. F.
Woolson, and M. D. Hansen. Baseline nih stroke scale score strongly predicts
outcome after stroke: A report of the trial of org 10172 in acute stroke treatment
(toast). Neurology, 53(1):126–31, 1999.
R. Aguirre-Hernandez and V. T. Farewell. A pearson-type goodness-of-fit test for stationary
and time-continuous markov regression models. Stat Med, 21(13):1899–911, 2002.
ISSN 0277-6715 (Print) 0277-6715. doi: 10.1002/sim.1152. Aguirre-Hernandez, R
Farewell, V T Journal Article England Stat Med. 2002 Jul 15;21(13):1899-911.
Yonghong An, A Texas, Yingyao Hu, and Matt Shum. Identifiability and inference of hidden
markov models. Technical report, 2013.
S. Atagi, M. Kawahara, A. Yokoyama, H. Okamoto, N. Yamamoto, Y. Ohe, T. Sawa, S. Ishikura,
T. Shibata, H. Fukuda, N. Saijo, and T. Tamura. Thoracic radiotherapy with
or without daily low-dose carboplatin in elderly patients with non-small-cell lung
cancer: a randomised, controlled, phase 3 trial by the japan clinical oncology group
(jcog0301). Lancet Oncol, 13(7):671–8, 2012.
N. Bartolomeo, P. Trerotoli, and G. Serio. Progression of liver cirrhosis to hcc: an applica-
tion of hidden markov model. BMC Med Res Methodol, 11:38, 2011. ISSN 1471-
2288 (Electronic) 1471-2288 (Linking). doi: 10.1186/1471-2288-11-38. Bartolomeo,
Nicola Trerotoli, Paolo Serio, Gabriella England BMC Med Res Methodol. 2011
Apr 4;11:38. doi: 10.1186/1471-2288-11-38.
Leonard E. Baum and Ted Petrie. Statistical inference for probabilistic functions
of finite state markov chains. The Annals of Mathematical Statis-
tics, 37(6):1554–1563, 1966. ISSN 00034851. doi: 10.2307/2238772.
URL http://www.jstor.org/stable/2238772http://www.jstor.org/stable/
pdfplus/2238772.pdf?acceptTC=true.
Ted; Soules George; Weiss Norman. Baum, Leonard E.; Petrie. A maximization technique oc-
curring in the statistical analysis of probabilistic functions of markov chains. The
Annals of Mathematical Statistics, 41(1), 1970. doi: 10.1214/aoms/1177697196.
Melissa Dowd Begg and Stephen Lagakos. Loss in efficiency caused by omitting covariates and
misspecifying exposure in logistic regression models. Journal of the American Sta-
tistical Association, 88(421):166–170, 1993.
Sandra Blitz, Joanna Baxter, Janet Raboud, Sharon Walmsley, Anita Rachlis, Fiona Smaill,
Alex Ferenczy, François Coutlée, Catherine Hankins, Deborah Money, and for the
Canadian Women’s HIV Study Group. Evaluation of hiv and highly active an-
tiretroviral therapy on the natural history of human papillomavirus infection and
cervical cytopathologic findings in hiv-positive and high-risk hiv-negative women.
Journal of Infectious Diseases, 208(3):454–462, 2013. doi: 10.1093/infdis/jit181.
URL http://jid.oxfordjournals.org/content/208/3/454.abstract.
Kristy Elizabeth Boyer. The dialogue hmm project. URL http://people.engr.ncsu.edu/
keboyer/dialoguehmm.html.
D. E. Briggs, R. A. Felberg, M. D. Malkoff, P. Bratina, and J. C. Grotta. Should mild or moderate
stroke patients be admitted to an intensive care unit? Stroke, 32(4):871–6, 2001.
Joseph Broderick. Interventional management of stroke trial (ims iii): A phase iii clinical trial
examining whether a combined intravenous (iv) and intra-arterial (ia) approach
to recanalization is superior to standard iv rt-pa (activase R©) alone, 2013. URL
http://clinicaltrials.gov/show/NCT00359424NLMIdentifier:NCT00359424.
J. P. Buonaccorsi, P. Laake, and M. B. Veierod. On the effect of misclassification on bias of
perfectly measured covariates in regression. Biometrics, 61(3):831–6, 2005.
A. Bureau, S. Shiboski, and J. P. Hughes. Applications of continuous time hidden markov models
to the study of misclassified disease outcomes. Stat Med, 22(3):441–62, 2003.
T. C. Buter, A. van den Hout, F. E. Matthews, J. P. Larsen, C. Brayne, and D. Aarsland. Dementia
and survival in parkinson disease: A 12-year population study. Neurology, 70(13):
1017–1022, 2008.
Jeffrey S. Buzas. Measurement error and misclassification in statistics and epidemiology: Impacts
and bayesian adjustments by p. gustafson. Biometrics, 62(1):307–308, 2006.
R.J. Carroll, D. Ruppert, L.A. Stefanski, and C.M. Crainiceanu. Measurement Error in Nonlinear
Models: A Modern Perspective, Second Edition. Taylor & Francis, 2006.
T. C. Chalmers, Jr. Smith, H., B. Blackburn, B. Silverman, B. Schroeder, D. Reitman, and
A. Ambroz. A method for assessing the quality of a randomized control trial.
Control Clin Trials, 2(1):31–49, 1981.
Zhijian Chen, Grace Y. Yi, and Changbao Wu. Marginal analysis of longitudinal ordinal data
with misclassification in both response and covariates. Biometrical Journal, 56(1):
69–85, 2014.
J. R. Cook and L. A. Stefanski. Simulation-extrapolation estimation in parametric measurement
error models. Journal of the American Statistical Association, 89(428):1314–1328,
1994.
L Costas, C Infante-Rivard, JP Zock, M Van Tongeren, P Boffetta, A Cusson, C Robles,
D Casabonne, Y Benavente, and N Becker. Occupational exposure to endocrine
disruptors and lymphoma risk in a multi-centric european study. British journal
of cancer, 2015. ISSN 0007-0920.
R. De Haan, J. Horn, M. Limburg, J. Van Der Meulen, and P. Bossuyt. A comparison of five
stroke scales with measures of disability, handicap, and quality of life. Stroke, 24
(8):1178–81, 1993.
Peter Diggle, Patrick Heagerty, Kung-Yee Liang, and Scott Zeger. Analysis of longitudinal data.
Oxford University Press, 2002. ISBN 0191664324.
Bradley Efron. Forcing a sequential experiment to be balanced. Biometrika, 58(3):403–417, 1971.
R. J. Ellis, S. Letendre, F. Vaida, R. Haubrich, R. K. Heaton, N. Sacktor, D. B. Clifford, B. M.
Best, S. May, A. Umlauf, M. Cherner, C. Sanders, C. Ballard, D. M. Simpson,
C. Jay, and J. A. McCutchan. Randomized trial of central nervous system-targeted
antiretrovirals for hiv-associated neurocognitive disorder. Clin Infect Dis, 58(7):
1015–22, 2014.
M. Ersek, N. Polissar, A. D. Pen, A. Jablonski, K. Herr, and M. B. Neradilek. Addressing
methodological challenges in implementing the nursing home pain management
algorithm randomized controlled trial. Clin Trials, 9(5):634–44, 2012.
L. Fan, S. D. Yeatts, B. J. Wolf, L. A. McClure, M. Selim, and Y. Y. Palesch. The impact
of covariate misclassification using generalized linear regression under covariate-
adaptive randomization. Stat Methods Med Res, 2015. ISSN 0962-2802. doi:
10.1177/0962280215616405.
U. Fischer, M. Arnold, K. Nedeltchev, C. Brekenfeld, P. Ballinari, L. Remonda, G. Schroth, and
H. P. Mattle. Nihss score and arteriographic findings in acute ischemic stroke.
Stroke, 36(10):2121–5, 2005.
K. M. Flegal, C. Brownie, and J. D. Haas. The effects of exposure misclassification on estimates
of relative risk. Am J Epidemiol, 123(4):736–51, 1986.
M. R. Frankel, L. B. Morgenstern, T. Kwiatkowski, M. Lu, B. C. Tilley, J. P. Broderick, R. Libman,
S. R. Levine, and T. Brott. Predicting prognosis after stroke: a placebo group
analysis from the national institute of neurological disorders and stroke rt-pa stroke
trial. Neurology, 55(7):952–9, 2000.
Hironori Fujisawa and Shizue Izumi. Inference about misclassification probabilities from repeated
binary responses. Biometrics, 56(3):706–711, 2000.
M. H. Gail, S. Wieand, and S. Piantadosi. Biased estimates of treatment effect in randomized
experiments with nonlinear regressions and omitted covariates. Biometrika, 71(3):
431, 1984.
R. E. Gangnon, K. E. Lee, B. E. Klein, S. K. Iyengar, T. A. Sivakumaran, and R. Klein. Misclassi-
fication can explain most apparent regression of age-related macular degeneration:
results from multistate models with misclassification. Invest Ophthalmol Vis Sci,
55(3):1780–6, 2014.
M. Maria Glymour, Lisa F. Berkman, Karen A. Ertel, Martha E. Fay, Thomas A. Glass, and
Karen L. Furie. Lesion characteristics, nih stroke scale, and functional recovery
after stroke. American journal of physical medicine & rehabilitation / Association
of Academic Physiatrists, 86(9):725–733, 2007.
Steven M. Green. Cheerio, laddie! bidding farewell to the glasgow coma scale. Annals of Emer-
gency Medicine, 58(5):427–430, 2011.
S. Greenland. The effect of misclassification in the presence of covariates. Am J Epidemiol, 112
(4):564–9, 1980.
J. K. Harrison, K. S. McArthur, and T. J. Quinn. Assessment scales in stroke: clinimetric and
clinical considerations. Clin Interv Aging, 8:201–11, 2013.
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